Quarterly Report (10-q)

false--01-02Q2202000013598412.002.002.0000000.150.300.150.300.150.300.150.300.010.010.01200000000020000000002000000000361530648362449037348092986361530648362449037348092986141100026160001794000306600019150003573000403100032490000.010.010.01500000005000000050000000000000 0001359841 2019-12-29 2020-06-27 0001359841 2020-07-24 0001359841 2018-12-30 2019-06-29 0001359841 2019-03-31 2019-06-29 0001359841 2020-03-29 2020-06-27 0001359841 2019-06-29 0001359841 2020-06-27 0001359841 2019-12-28 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-29 0001359841 us-gaap:CommonStockMember 2019-03-30 0001359841 us-gaap:RetainedEarningsMember 2019-06-29 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 2019-06-29 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-30 0001359841 us-gaap:CommonStockMember 2019-06-29 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-03-30 0001359841 us-gaap:RetainedEarningsMember 2019-03-31 2019-06-29 0001359841 2019-03-30 0001359841 us-gaap:RetainedEarningsMember 2019-03-30 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-06-29 0001359841 us-gaap:CommonStockMember 2019-03-31 2019-06-29 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 2019-06-29 0001359841 us-gaap:AdditionalPaidInCapitalMember 2018-12-30 2019-06-29 0001359841 us-gaap:CommonStockMember 2018-12-29 0001359841 us-gaap:RetainedEarningsMember 2018-12-30 2019-06-29 0001359841 us-gaap:AdditionalPaidInCapitalMember 2018-12-29 0001359841 us-gaap:CommonStockMember 2018-12-30 2019-06-29 0001359841 us-gaap:RetainedEarningsMember 2018-12-29 0001359841 2018-12-29 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-06-29 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-29 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-12-29 2020-06-27 0001359841 us-gaap:RetainedEarningsMember 2019-12-29 2020-06-27 0001359841 us-gaap:CommonStockMember 2020-06-27 0001359841 us-gaap:CommonStockMember 2019-12-29 2020-06-27 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-28 0001359841 us-gaap:CommonStockMember 2019-12-28 0001359841 us-gaap:RetainedEarningsMember 2019-12-28 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-12-28 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-06-27 0001359841 us-gaap:AdditionalPaidInCapitalMember 2020-06-27 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-27 0001359841 us-gaap:RetainedEarningsMember 2020-06-27 0001359841 us-gaap:RetainedEarningsMember 2020-03-29 2020-06-27 0001359841 2020-03-28 0001359841 us-gaap:CommonStockMember 2020-03-28 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-28 0001359841 us-gaap:RetainedEarningsMember 2020-03-28 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-29 2020-06-27 0001359841 us-gaap:AdditionalPaidInCapitalMember 2020-03-29 2020-06-27 0001359841 us-gaap:CommonStockMember 2020-03-29 2020-06-27 0001359841 us-gaap:AdditionalPaidInCapitalMember 2020-03-28 0001359841 2018-12-30 2019-12-28 0001359841 hbi:A5.375SeniorNotesMember 2020-06-27 0001359841 hbi:RevolvingLoanFacilityMember 2019-12-29 2020-03-28 0001359841 hbi:RevolvingLoanFacilityMember 2020-03-29 2020-06-27 0001359841 hbi:A5.375SeniorNotesMember 2019-12-29 2020-06-27 0001359841 hbi:ThirdpartybrickandmortarMember 2019-03-31 2019-06-29 0001359841 hbi:ThirdpartybrickandmortarMember 2018-12-30 2019-06-29 0001359841 us-gaap:SalesChannelDirectlyToConsumerMember 2020-03-29 2020-06-27 0001359841 hbi:ThirdpartybrickandmortarMember 2020-03-29 2020-06-27 0001359841 us-gaap:SalesChannelDirectlyToConsumerMember 2019-03-31 2019-06-29 0001359841 hbi:ThirdpartybrickandmortarMember 2019-12-29 2020-06-27 0001359841 us-gaap:SalesChannelDirectlyToConsumerMember 2019-12-29 2020-06-27 0001359841 us-gaap:SalesChannelDirectlyToConsumerMember 2018-12-30 2019-06-29 0001359841 us-gaap:GovernmentContractMember 2020-06-27 0001359841 us-gaap:GovernmentContractMember hbi:ThirdpartybrickandmortarMember 2020-03-29 2020-06-27 0001359841 hbi:BrasNThingsMember 2018-02-12 2018-02-12 0001359841 hbi:BrasNThingsMember 2019-06-30 2019-09-28 0001359841 hbi:BrasNThingsMember 2017-12-31 2018-12-29 0001359841 hbi:BrasNThingsMember 2018-02-12 0001359841 hbi:BrasNThingsMember 2018-12-30 2019-03-30 0001359841 us-gaap:RestrictedStockUnitsRSUMember 2019-12-29 2020-06-27 0001359841 us-gaap:EmployeeStockMember 2018-12-30 2019-06-29 0001359841 us-gaap:RestrictedStockUnitsRSUMember 2018-12-30 2019-06-29 0001359841 us-gaap:EmployeeStockMember 2019-03-31 2019-06-29 0001359841 us-gaap:RestrictedStockUnitsRSUMember 2020-03-29 2020-06-27 0001359841 us-gaap:RestrictedStockUnitsRSUMember 2019-03-31 2019-06-29 0001359841 us-gaap:StockOptionMember 2019-12-29 2020-06-27 0001359841 us-gaap:EmployeeStockMember 2020-03-29 2020-06-27 0001359841 us-gaap:StockOptionMember 2020-03-29 2020-06-27 0001359841 us-gaap:EmployeeStockMember 2019-12-29 2020-06-27 0001359841 us-gaap:StockOptionMember 2019-03-31 2019-06-29 0001359841 us-gaap:StockOptionMember 2018-12-30 2019-06-29 0001359841 hbi:A2020ShareRepurchasePlanMemberMember 2019-12-29 2020-06-27 0001359841 hbi:A2016ShareRepurchasePlanMember 2016-04-27 0001359841 hbi:A2020ShareRepurchasePlanMemberMember 2020-06-27 0001359841 us-gaap:SubsequentEventMember 2020-07-28 2020-07-28 0001359841 hbi:A2020ShareRepurchasePlanMemberMember 2020-02-06 0001359841 hbi:AccountsReceivableSecuritizationFacilityMember 2019-12-28 0001359841 hbi:AccountsReceivableSecuritizationFacilityMember 2020-06-27 0001359841 hbi:RevolvingLoanFacilityMember 2020-06-27 0001359841 srt:MaximumMember hbi:A5.375SeniorNotesMember us-gaap:SubsequentEventMember 2020-05-04 2022-05-15 0001359841 hbi:AustralianRevolvingFacilityMember 2020-06-27 0001359841 hbi:AccountsReceivableSecuritizationFacilityMember 2020-03-28 0001359841 hbi:SeniorSecuredCreditFacilityMember 2020-06-27 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-04-04 2021-07-03 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-01-02 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-07-03 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-04-03 0001359841 hbi:OtherInternationalDebtMember 2020-06-27 0001359841 srt:MinimumMember hbi:SeniorSecuredCreditFacilityMember 2020-06-27 0001359841 hbi:SeniorSecuredCreditFacilityMember 2020-03-29 2020-06-27 0001359841 srt:MaximumMember hbi:SeniorSecuredCreditFacilityMember 2020-06-27 0001359841 hbi:SeniorSecuredCreditFacilityMember 2019-12-29 2020-03-28 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-09-26 0001359841 hbi:RedemptionwithamakewholepremiumMember hbi:A5.375SeniorNotesMember us-gaap:SubsequentEventMember 2020-05-04 2022-05-15 0001359841 hbi:RedemptionduetoachangeofcontroloftheCompanyMember hbi:A5.375SeniorNotesMember us-gaap:SubsequentEventMember 2020-05-04 2022-05-15 0001359841 hbi:EuropeanRevolvingLoanFacilityMember 2020-06-27 0001359841 hbi:RedemptionwithaportionofnetproceedsfromequityofferingsMember hbi:A5.375SeniorNotesMember us-gaap:SubsequentEventMember 2020-05-04 2022-05-15 0001359841 hbi:A4.625SeniorNotesMember 2020-06-27 0001359841 hbi:A4.625SeniorNotesMember 2019-12-28 0001359841 hbi:A3.50SeniorNotesMember 2020-06-27 0001359841 hbi:A3.50SeniorNotesMember 2019-12-28 0001359841 hbi:TermLoanBMember 2020-06-27 0001359841 hbi:TermLoanAMember 2019-12-28 0001359841 hbi:EuropeanRevolvingLoanFacilityMember 2019-12-28 0001359841 hbi:AustralianRevolvingFacilityMember 2019-12-28 0001359841 hbi:RevolvingLoanFacilityMember 2019-12-28 0001359841 hbi:TermLoanAMember 2020-06-27 0001359841 hbi:A4.875SeniorNotesMember 2020-06-27 0001359841 hbi:TermLoanBMember 2019-12-28 0001359841 hbi:A4.875SeniorNotesMember 2019-12-28 0001359841 hbi:A5.375SeniorNotesMember 2019-12-28 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-09-27 2021-01-02 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-01-03 2021-04-03 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-06-28 2020-09-26 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-29 2020-06-27 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2019-03-31 2019-06-29 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2019-12-29 2020-06-27 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-06-27 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2018-12-30 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-30 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-29 2020-06-27 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-06-29 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-03-31 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-03-31 2019-06-29 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2020-03-29 2020-06-27 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-03-29 2020-06-27 0001359841 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-29 2020-06-27 0001359841 hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2019-12-28 0001359841 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-28 0001359841 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-27 0001359841 hbi:IncometaxesMember 2019-12-29 2020-06-27 0001359841 hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2019-12-29 2020-06-27 0001359841 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-29 2020-06-27 0001359841 hbi:IncometaxesMember 2019-12-28 0001359841 hbi:IncometaxesMember 2020-06-27 0001359841 hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2020-06-27 0001359841 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-06-27 0001359841 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-28 0001359841 hbi:EurodenominatedLongtermDebtMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 2019-06-29 0001359841 us-gaap:CurrencySwapMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-29 2020-06-27 0001359841 hbi:EurodenominatedLongtermDebtMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-29 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-06-29 0001359841 hbi:EurodenominatedLongtermDebtMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 2019-06-29 0001359841 hbi:EurodenominatedLongtermDebtMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember 2018-12-30 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-03-29 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-03-31 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-12-29 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-12-30 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember 2019-12-29 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember 2019-03-31 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-12-29 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-03-29 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-31 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember 2020-03-29 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2018-12-30 2019-06-29 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-27 0001359841 us-gaap:LiabilitiesTotalMember 2019-12-28 0001359841 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-27 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-06-27 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-28 0001359841 us-gaap:AssetsTotalMember 2020-06-27 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 us-gaap:LiabilitiesTotalMember 2020-06-27 0001359841 hbi:OtherCurrentAssetMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-06-27 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-27 0001359841 hbi:OtherCurrentAssetMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-27 0001359841 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 us-gaap:AssetsTotalMember 2019-12-28 0001359841 hbi:EurodenominatedLongtermDebtMember hbi:A3.50SeniorNotesMember 2019-07-10 2019-07-10 0001359841 us-gaap:ForeignExchangeContractMember 2020-06-27 0001359841 us-gaap:CurrencySwapMember 2019-07-10 0001359841 us-gaap:CurrencySwapMember 2020-06-27 0001359841 hbi:A4.625SeniorNotesMember us-gaap:CurrencySwapMember 2020-06-27 0001359841 hbi:EurodenominatedLongtermDebtMember hbi:A3.50SeniorNotesMember 2019-12-29 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:InterestExpenseMember 2019-12-29 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:InterestExpenseMember 2018-12-30 2019-06-29 0001359841 us-gaap:CurrencySwapMember us-gaap:InterestExpenseMember 2020-03-29 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:InterestExpenseMember 2019-03-31 2019-06-29 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueInputsLevel2Member 2020-06-27 0001359841 us-gaap:FairValueInputsLevel2Member 2019-12-28 0001359841 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001359841 hbi:ActivewearMember 2020-03-29 2020-06-27 0001359841 hbi:InnerwearMember 2019-03-31 2019-06-29 0001359841 hbi:OperatingSegmentMember 2018-12-30 2019-06-29 0001359841 hbi:OperatingSegmentMember 2019-12-29 2020-06-27 0001359841 hbi:InternationalMember 2020-03-29 2020-06-27 0001359841 hbi:OperatingSegmentMember 2020-03-29 2020-06-27 0001359841 hbi:InnerwearMember 2019-12-29 2020-06-27 0001359841 hbi:InternationalMember 2019-12-29 2020-06-27 0001359841 us-gaap:CorporateNonSegmentMember 2018-12-30 2019-06-29 0001359841 hbi:InternationalMember 2018-12-30 2019-06-29 0001359841 hbi:InnerwearMember 2018-12-30 2019-06-29 0001359841 us-gaap:CorporateNonSegmentMember 2020-03-29 2020-06-27 0001359841 hbi:ActivewearMember 2018-12-30 2019-06-29 0001359841 hbi:InternationalMember 2019-03-31 2019-06-29 0001359841 hbi:InnerwearMember 2020-03-29 2020-06-27 0001359841 hbi:ActivewearMember 2019-03-31 2019-06-29 0001359841 hbi:ActivewearMember 2019-12-29 2020-06-27 0001359841 us-gaap:CorporateNonSegmentMember 2019-12-29 2020-06-27 0001359841 hbi:OperatingSegmentMember 2019-03-31 2019-06-29 0001359841 us-gaap:CorporateNonSegmentMember 2019-03-31 2019-06-29 0001359841 hbi:TotalMember 2019-12-29 2020-06-27 0001359841 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-12-29 2020-06-27 0001359841 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-31 2019-06-29 0001359841 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-03-29 2020-06-27 0001359841 us-gaap:CostOfSalesMember 2019-12-29 2020-06-27 0001359841 us-gaap:AccruedLiabilitiesMember 2020-06-27 0001359841 us-gaap:OtherNoncurrentLiabilitiesMember 2020-06-27 0001359841 us-gaap:CostOfSalesMember 2020-03-29 2020-06-27 0001359841 hbi:TotalMember 2020-03-29 2020-06-27 0001359841 hbi:TotalMember 2018-12-30 2019-06-29 0001359841 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-12-30 2019-06-29 0001359841 hbi:TotalMember 2019-03-31 2019-06-29 0001359841 us-gaap:CostOfSalesMember 2018-12-30 2019-06-29 0001359841 us-gaap:CostOfSalesMember 2019-03-31 2019-06-29 0001359841 srt:ScenarioPreviouslyReportedMember 2019-03-30 0001359841 srt:RestatementAdjustmentMember 2019-06-29 0001359841 srt:ScenarioPreviouslyReportedMember 2019-03-31 2019-06-29 0001359841 hbi:AsRevisedMember 2019-03-31 2019-06-29 0001359841 srt:RestatementAdjustmentMember 2019-03-30 0001359841 srt:RestatementAdjustmentMember 2019-03-31 2019-06-29 0001359841 srt:ScenarioPreviouslyReportedMember 2019-06-29 0001359841 hbi:AsRevisedMember 2019-06-29 0001359841 hbi:AsRevisedMember 2019-03-30 0001359841 srt:ScenarioPreviouslyReportedMember 2018-12-30 2019-06-29 0001359841 srt:RestatementAdjustmentMember 2018-12-30 2019-06-29 0001359841 srt:RestatementAdjustmentMember 2018-12-29 0001359841 hbi:AsRevisedMember 2018-12-29 0001359841 hbi:AsRevisedMember 2018-12-30 2019-06-29 0001359841 srt:ScenarioPreviouslyReportedMember 2018-12-29 0001359841 srt:ScenarioPreviouslyReportedMember 2019-06-30 2019-09-28 0001359841 srt:RestatementAdjustmentMember 2019-06-30 2019-09-28 0001359841 hbi:AsRevisedMember 2019-06-30 2019-09-28 0001359841 hbi:AsRevisedMember 2018-12-30 2019-09-28 0001359841 srt:RestatementAdjustmentMember 2018-12-30 2019-09-28 0001359841 srt:ScenarioPreviouslyReportedMember 2018-12-30 2019-09-28 0001359841 srt:RestatementAdjustmentMember 2019-09-28 0001359841 hbi:AsRevisedMember 2019-09-28 0001359841 srt:ScenarioPreviouslyReportedMember 2019-09-28 xbrli:pure iso4217:USD xbrli:shares iso4217:AUD iso4217:USD iso4217:EUR xbrli:shares

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q



☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 27, 2020



☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-32891

Hanesbrands Inc.

(Exact name of registrant as specified in its charter)



Maryland		20-3552316
(State of incorporation)		(I.R.S. employer identification no.)

1000 East Hanes Mill Road
Winston-Salem,	North Carolina	27105
(Address of principal executive office)		(Zip code)

(336) 519-8080

(Registrant’s telephone number including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):



Large accelerated filer	☒	Accelerated filer	☐

Non-accelerated filer	☐	Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, Par Value $0.01	HBI	New York Stock Exchange

As of July 24, 2020, there were 348,160,775 shares of the registrant’s common stock outstanding.

Table of Contents

TABLE OF CONTENTS



		Page
Forward-Looking Statements		1

PART I
Item 1.	Financial Statements (unaudited):
	Condensed Consolidated Statements of Income for the quarters and six months ended June 27, 2020 and June 29, 2019	2
	Condensed Consolidated Statements of Comprehensive Income for the quarters and six months ended June 27, 2020 and June 29, 2019	3
	Condensed Consolidated Balance Sheets at June 27, 2020, December 28, 2019 and June 29, 2019	4
	Condensed Consolidated Statements of Stockholders’ Equity for the quarters and six months ended June 27, 2020 and June 29, 2019	5
	Condensed Consolidated Statements of Cash Flows for the six months ended June 27, 2020 and June 29, 2019	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	39
Item 4.	Controls and Procedures	39

PART II
Item 1.	Legal Proceedings	40
Item 1A.	Risk Factors	41
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3.	Defaults Upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	43
Signatures		44

Table of Contents

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains information that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). Forward-looking statements include all statements that do not relate solely to historical or current facts, and can generally be identified by the use of words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “intend,” “anticipate,” “plan,” “continue” or similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements regarding our intent, belief and current expectations about our strategic direction, prospects and future results are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. In particular, statements with respect to trends associated with our business, our future financial performance and the potential effects of the global COVID-19 coronavirus outbreak included in this Quarterly Report on Form 10-Q specifically appearing under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” include forward-looking statements.

More information on factors that could cause actual results or events to differ materially from those anticipated is included from time to time in our reports filed with the Securities and Exchange Commission (the “SEC”), including this Quarterly Report on Form 10-Q, our Quarterly Report on Form 10-Q for the quarter end March 28, 2020 and our Annual Report on Form 10-K for the year ended December 28, 2019, under the caption “Risk Factors,” and available on the “Investors” section of our corporate website, www.Hanes.com/investors. The contents of our corporate website are not incorporated by reference in this Quarterly Report on Form 10-Q.

Table of Contents

PART I



Item 1.	Financial Statements

HANESBRANDS INC.

Condensed Consolidated Statements of Income

(in thousands, except per share amounts)

(unaudited)



	Quarters Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net sales	$	1,738,779	$	1,760,927	$	3,055,241	$	3,348,951
Cost of sales	1,105,767		1,085,404		1,948,497		2,053,397
Gross profit	633,012		675,523		1,106,744		1,295,554
Selling, general and administrative expenses	391,476		445,923		831,078		916,310
Operating profit	241,536		229,600		275,666		379,244
Other expenses	5,050		8,249		11,540		15,700
Interest expense, net	41,659		46,522		78,508		94,581
Income before income tax expense	194,827		174,829		185,618		268,963
Income tax expense	33,646		25,274		32,311		38,320
Net income	$	161,181	$	149,555	$	153,307	$	230,643

Earnings per share:
Basic	$	0.46	$	0.41	$	0.43	$	0.63
Diluted	$	0.46	$	0.41	$	0.43	$	0.63

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

HANESBRANDS INC.

Condensed Consolidated Statements of Comprehensive Income

(in thousands)

(unaudited)



	Quarters Ended						Six Months Ended
	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Net income	$	161,181		$	149,555		$	153,307		$	230,643
Other comprehensive income (loss):
Translation adjustments	95,033			(3,202		)	(22,121		)	4,184
Unrealized gain (loss) on qualifying cash flow hedges, net of tax of $4,031, $1,915, $(3,249) and $3,573, respectively	(6,177		)	(5,158		)	1,606			(9,077		)
Unrecognized income from pension and postretirement plans, net of tax of $(1,794), $(1,411), $(3,066) and $(2,616), respectively	3,560			3,553			7,154			6,950
Total other comprehensive income (loss)	92,416			(4,807		)	(13,361		)	2,057
Comprehensive income	$	253,597		$	144,748		$	139,946		$	232,700

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

HANESBRANDS INC.

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

(unaudited)



	June 27, 2020			December 28, 2019			June 29, 2019
Assets
Cash and cash equivalents	$	683,114		$	328,876		$	257,941
Trade accounts receivable, net	1,196,826			815,210			1,011,816
Inventories	1,958,443			1,905,845			2,223,199
Other current assets	193,422			174,634			176,296
Total current assets	4,031,805			3,224,565			3,669,252
Property, net	565,849			587,896			597,444
Right-of-use assets	479,677			487,787			484,168
Trademarks and other identifiable intangibles, net	1,478,721			1,520,800			1,541,306
Goodwill	1,233,184			1,235,711			1,240,853
Deferred tax assets	200,047			203,331			220,927
Other noncurrent assets	123,677			93,896			92,087
Total assets	$	8,112,960		$	7,353,986		$	7,846,037

Liabilities and Stockholders’ Equity
Accounts payable	$	1,152,273		$	959,006		$	1,026,863
Accrued liabilities	568,228			531,184			561,172
Lease liabilities	160,432			166,091			144,453
Notes payable	8,803			4,244			4,695
Accounts Receivable Securitization Facility	—			—			190,311
Current portion of long-term debt	112,512			110,914			156,189
Total current liabilities	2,002,248			1,771,439			2,083,683
Long-term debt	3,985,631			3,256,870			3,671,066
Lease liabilities - noncurrent	362,570			358,281			371,964
Pension and postretirement benefits	374,052			403,458			351,453
Other noncurrent liabilities	309,139			327,343			342,485
Total liabilities	7,033,640			6,117,391			6,820,651

Stockholders’ equity:
Preferred stock (50,000,000 authorized shares; $.01 par value)
Issued and outstanding — None	—			—			—
Common stock (2,000,000,000 authorized shares; $.01 par value)
Issued and outstanding — 348,092,986, 362,449,037 and 361,530,648, respectively	3,481			3,624			3,615
Additional paid-in capital	302,522			304,395			308,555
Retained earnings	1,404,326			1,546,224			1,285,842
Accumulated other comprehensive loss	(631,009		)	(617,648		)	(572,626		)
Total stockholders’ equity	1,079,320			1,236,595			1,025,386
Total liabilities and stockholders’ equity	$	8,112,960		$	7,353,986		$	7,846,037

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

HANESBRANDS INC.

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except per share data)

(unaudited)



	Common Stock			Additional Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total
	Shares	Amount		Additional Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total
Balances at March 28, 2020	348,035	$	3,480	$	297,456	$	1,296,060		$	(723,425	)	$	873,571
Net income	—	—		—		161,181			—			161,181
Dividends ($0.15 per common share)	—	—		—		(52,915		)	—			(52,915		)
Other comprehensive income	—	—		—		—			92,416			92,416
Stock-based compensation	—	—		4,393		—			—			4,393
Net exercise of stock options, vesting of restricted stock units and other	58	1		673		—			—			674
Balances at June 27, 2020	348,093	$	3,481	$	302,522	$	1,404,326		$	(631,009	)	$	1,079,320



	Common Stock					Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total
	Shares		Amount			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total
Balances at December 28, 2019	362,449		$	3,624		$	304,395		$	1,546,224		$	(617,648	)	$	1,236,595
Net income	—		—			—			153,307			—			153,307
Dividends ($0.30 per common share)	—		—			—			(107,336		)	—			(107,336		)
Other comprehensive loss	—		—			—			—			(13,361		)	(13,361		)
Stock-based compensation	—		—			9,034			—			—			9,034
Net exercise of stock options, vesting of restricted stock units and other	108		2			1,348			—			—			1,350
Share repurchases	(14,464	)	(145		)	(12,255		)	(187,869		)	—			(200,269		)
Balances at June 27, 2020	348,093		$	3,481		$	302,522		$	1,404,326		$	(631,009	)	$	1,079,320

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

HANESBRANDS INC.

Condensed Consolidated Statements of Stockholders’ Equity - (Continued)

(in thousands, except per share data)

(unaudited)



	Common Stock			Additional Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total
	Shares	Amount		Additional Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total
Balances at March 30, 2019	361,471	$	3,615	$	306,084	$	1,191,111		$	(567,819	)	$	932,991
Net income	—	—		—		149,555			—			149,555
Dividends ($0.15 per common share)	—	—		—		(54,824		)	—			(54,824		)
Other comprehensive loss	—	—		—		—			(4,807		)	(4,807		)
Stock-based compensation	—	—		1,982		—			—			1,982
Net exercise of stock options, vesting of restricted stock units and other	60	—		489		—			—			489
Balances at June 29, 2019	361,531	$	3,615	$	308,555	$	1,285,842		$	(572,626	)	$	1,025,386



	Common Stock			Additional Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total
	Shares	Amount		Additional Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total
Balances at December 29, 2018	361,330	$	3,613	$	284,877	$	1,079,503		$	(495,867	)	$	872,126
Net income	—	—		—		230,643			—			230,643
Dividends ($0.30 per common share)	—	—		—		(109,676		)	—			(109,676		)
Other comprehensive income	—	—		—		—			2,057			2,057
Stock-based compensation	—	—		7,039		—			—			7,039
Net exercise of stock options, vesting of restricted stock units and other	201	2		2,265		—			—			2,267
Modification of deferred compensation plans	—	—		14,374		—			—			14,374
Cumulative effect of change in adoption of leases standard	—	—		—		6,556			—			6,556
Stranded tax related to U.S. pension plan	—	—		—		78,816			(78,816		)	—
Balances at June 29, 2019	361,531	$	3,615	$	308,555	$	1,285,842		$	(572,626	)	$	1,025,386

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

HANESBRANDS INC. Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited)

	Six Months Ended
	June 27, 2020			June 29, 2019
Operating activities:
Net income	$	153,307		$	230,643
Adjustments to reconcile net income to net cash from operating activities:
Depreciation	45,399			46,889
Amortization of acquisition intangibles	12,199			12,537
Other amortization	5,107			5,063
Impairment of intangible assets	20,319			—
Amortization of debt issuance costs	5,119			4,758
Stock compensation expense	9,189			7,247
Deferred taxes	(2,201		)	(2,582		)
Other	9,259			5,475
Changes in assets and liabilities:
Accounts receivable	(392,134		)	(137,445		)
Inventories	(61,409		)	(165,512		)
Other assets	(31,570		)	(28,579		)
Accounts payable	210,338			7,699
Accrued pension and postretirement benefits	(19,318		)	(18,321		)
Accrued liabilities and other	18,603			(25,235		)
Net cash from operating activities	(17,793		)	(57,363		)
Investing activities:
Capital expenditures	(46,512		)	(58,285		)
Proceeds from sales of assets	66			518
Other	5,823			—
Net cash from investing activities	(40,623		)	(57,767		)
Financing activities:
Borrowings on notes payable	116,669			162,592
Repayments on notes payable	(112,373		)	(163,703		)
Borrowings on Accounts Receivable Securitization Facility	227,061			123,812
Repayments on Accounts Receivable Securitization Facility	(227,061		)	(95,110		)
Borrowings on Revolving Loan Facilities	1,638,000			1,602,500
Repayments on Revolving Loan Facilities	(1,638,000		)	(1,422,500		)
Borrowings on Senior Notes	700,000			—
Repayments on Term Loan Facilities	—			(141,623		)
Borrowings on International Debt	31,222			7,141
Repayments on International Debt	—			(27,941		)
Share repurchases	(200,269		)	—
Cash dividends paid	(105,896		)	(108,449		)
Payments of debt issuance costs	(14,834		)	(768		)
Taxes paid related to net shares settlement of equity awards	(80		)	(1,157		)
Other	879			985
Net cash from financing activities	415,318			(64,221		)
Effect of changes in foreign exchange rates on cash	(2,669		)	4,282
Change in cash, cash equivalents and restricted cash	354,233			(175,069		)
Cash, cash equivalents and restricted cash at beginning of year	329,923			455,732
Cash, cash equivalents and restricted cash at end of period	684,156			280,663
Less restricted cash at end of period	1,042			22,722
Cash and cash equivalents per balance sheet at end of period	$	683,114		$	257,941

Capital expenditures included in accounts payable at June 27, 2020 and December 28, 2019, were $4,058 and $19,327, respectively. For the six months ended June 27, 2020 and June 29, 2019, right-of-use assets obtained in exchange for lease obligations were $23,769 and $38,840, respectively.

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements

(amounts in thousands, except per share data)

(unaudited)


(1)	Basis of Presentation

These statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, in accordance with those rules and regulations, do not include all information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Management believes that the disclosures made are adequate for a fair statement of the results of operations, financial condition and cash flows of Hanesbrands Inc. and its consolidated subsidiaries (the “Company” or “Hanesbrands”). In the opinion of management, the condensed consolidated interim financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the interim periods presented herein. The preparation of condensed consolidated interim financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts and disclosures. Actual results may vary from these estimates.

These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s 2019 Annual Report on Form 10-K. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year.

Liquidity and Impact of COVID-19

The COVID-19 global pandemic has impacted the Company’s business operations and results of operations for the second quarter and the first six months of 2020 due to decreased customer traffic and temporary retail store closures worldwide. The Company’s e-commerce sites have remained open in all regions. Most of the Company’s retail stores were reopened by the end of the second quarter but have and are expected to continue to experience significant reductions in traffic and therefore, revenue. Many of the Company’s wholesale customers have also substantially reduced their operations. The extent and duration of the global pandemic remains uncertain and may continue to impact consumer purchasing activity throughout the year. The evolving COVID-19 pandemic could continue to have an adverse impact on the Company’s results of operations and liquidity; the operations of the Company’s suppliers, vendors and customers; and employees as a result of quarantines, facility closures, and travel and other restrictions. While the ultimate global and economic impact of the COVID-19 pandemic remains highly uncertain, the Company expects its business operations and results of operations, including net sales, earnings and cash flows, will be materially impacted for at least the balance of 2020.

The Company relies on its cash flows generated from operations and the borrowing capacity under its credit facilities to meet the cash requirements of its business. The primary cash requirements of its business are payments to employees and vendors in the normal course of business, capital expenditures, maturities of debt and related interest payments, business acquisitions, contributions to its pension plans, repurchases of its stock, regular quarterly dividend payments and income tax payments. The Company is focused on preserving its liquidity and managing its cash flow during these unprecedented conditions with preemptive actions to enhance its ability to meet its short-term liquidity needs. Such actions include, but are not limited to, selling personal protective equipment (“PPE”) such as cloth face coverings and gowns; operating manufacturing and distribution facilities on a demand-adjusted basis; reducing discretionary spending such as certain media and marketing expenses; focused working capital management; reducing capital expenditures; suspending its share repurchase program until further notice; reducing payroll costs, through temporary employee furloughs and pay cuts; working globally to maximize the Company’s participation in all eligible government or other initiatives available to businesses or employees impacted by the COVID-19 pandemic; engaging with landlords to negotiate rent deferrals or other rent concessions; issuing new debt and amending certain existing debt facilities.

During the six months of 2020, the rapid expansion of the COVID-19 pandemic has resulted in a sharp decline in net sales and earnings in the Company’s apparel businesses. Sales of PPE used to help mitigate the spread of the COVID-19 virus partially offset the negative impact of the COVID-19 pandemic. In addition, the Company’s operating results also reflected impairment charges related to intangible assets, as well as additional charges to reserve for increased excess and obsolete inventory and bad debt charges due to the ongoing effects of the COVID-19 pandemic.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

In light of temporary store closures related to the COVID-19 pandemic, the Company has taken actions with respect to certain of its existing leases, including withholding rent payments and engaging with landlords in an attempt to obtain rent deferrals and other rent concessions. If such negotiations are not successful, the lease liabilities associated with those leases could become immediately due and payable. Consistent with updated guidance from the Financial Accounting Standards Board (“FASB”) in April 2020, the Company has elected to treat agreed-upon payment deferrals that result in the total payments required by the modified contract being substantially the same as total payments required by the contract as if there were no modifications to the lease contract. The Company has elected to treat other agreed-upon rent concessions which result in reduced minimum lease payments as variable lease payments. For any agreed-upon rent concessions which change the payment terms from minimum rental amounts to amounts based on a percentage of sales volume, the Company has elected to treat such changes as lease modifications under the current lease guidance.

Goodwill and indefinite-lived intangible assets are evaluated for impairment at least annually as of the first day of the third quarter, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit or intangible asset below its carrying values. During the second quarter of 2020, the Company completed a quantitative impairment analysis for certain indefinite-lived intangible assets as a result of the significant impact of the COVID-19 pandemic on their performance. Based on this analysis, the Company recorded impairment charges of $20,319 on trademarks and other intangible assets which are reflected in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. Although the Company determined that no impairment exists for the Company's goodwill, other indefinite-lived or definite-lived intangible assets, these assets could be at risk for impairment should global economic conditions continue to deteriorate as a result of the COVID-19 pandemic.

In March 2020, the Company drew down $630,000 under the Revolving Loan Facility as a precautionary measure, to provide the Company with additional financial flexibility to manage its business with a safety-first emphasis during the unknown duration and impact of the COVID-19 pandemic. The Company subsequently repaid $490,000 of its borrowings under the Revolving Loan Facility in April 2020. In May 2020, the Company issued $700,000 aggregate principal amount of 5.375% Senior Notes resulting in net proceeds of approximately $691,250 which were used to repay all outstanding borrowings under its Revolving Loan Facility, pay related fees and expenses, and for general corporate purposes.

As of June 27, 2020, the Company was in compliance with all financial covenants under its credit facilities and other outstanding indebtedness. In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 pandemic and the associated impact on future earnings, the Company amended its Senior Secured Credit Facility (as discussed in Note, “Debt and Notes Payable”) prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. After obtaining the debt amendment, which provides relief from certain covenants for a 15-month period and adds additional financial and non-financial covenants, the Company expects to maintain compliance with its covenants for at least one year from the date of these financial statements based on its current expectations and forecasts. If economic conditions caused by the COVID-19 pandemic worsen and the Company’s earnings and operating cash flows do not start to recover as currently estimated by management, this could impact the Company’s ability to maintain compliance with its amended financial covenants and require the Company to seek additional amendments to its Senior Secured Credit Facility. If the Company is not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, its lenders could require the Company to repay its outstanding debt. In that situation, the Company may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

Revisions of Previously Issued Consolidated Financial Statements

As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 28, 2019, during the fourth quarter of 2019 the Company identified tax errors, which originated prior to 2017, in its previously issued 2018 and 2017 annual consolidated financial statements and quarterly condensed consolidated interim financial statements for each of the quarterly periods of 2018 and the first three quarterly periods of 2019. Although the Company assessed the materiality of the errors and concluded that the errors were not material to the previously issued annual or interim financial statements, the Company did revise its previously issued 2018 and 2017 annual financial statements to correct for such tax errors in connection with the filing of its 2019 Annual Report on Form 10-K, and disclosed that it would be revising its 2019 condensed consolidated interim financial statements in connection with the filing of its Quarterly Reports on Form 10-Q during 2020. In connection with such revision, the Company also corrected for certain other immaterial errors. In connection with the filing of this Quarterly Report on Form 10-Q, the Company has revised the accompanying condensed consolidated interim financial statements as of and for the quarter and six months ended June 29, 2019 to correct for the impact of such errors, including the impact to retained earnings as of June 29, 2019 to correct for the errors which originated in periods prior to 2019, which primarily related to the tax errors. The accompanying footnotes have also been corrected to reflect the impact of the revisions of the previously filed condensed consolidated interim consolidated financial statements.

Additionally, in connection with the filing of this Quarterly Report on Form 10-Q, the Company has disclosed the impact of the revisions to the condensed consolidated interim financial statements as of and for the quarter and nine months ended September 28, 2019 to correct for the impact of such errors. The Company will effect the revision of its unaudited condensed consolidated interim financial statements as of and for the quarter and nine months ended September 28, 2019 with the future filing of its Quarterly Report on Form 10-Q for the period ended September 26, 2020. See Note, "Revisions of Previously Issued Condensed Consolidated Interim Financial Statements" for reconciliations between as reported and as revised amounts as of and for the periods ended June 29, 2019 and September 28, 2019.


(2)	Recent Accounting Pronouncements

Financial Instruments - Credit Losses

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. The new accounting rules eliminate the probable initial recognition threshold and, instead, reflect an entity’s current estimate of all expected credit losses. The new accounting rules were effective for the Company in the first quarter of 2020 and applies to its trade receivables.

Under the new accounting rules, trade receivables are now evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics. These classifications will be reassessed at each measurement date. A combination of factors, such as industry trends, customers’ financial strength, credit standing and payment and default history are considered in determining the appropriate estimate of expected credit losses. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows.

Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new accounting rules simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test which previously measured a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. The new accounting rules were effective for the Company in the first quarter of 2020. As a result of adopting the new rules, the Company will compare the estimated fair value of its reporting units to their respective carrying values when evaluating the recoverability of goodwill. If the carrying value of a reporting unit exceeds its fair value, an impairment charge will be recognized for the amount by which its carrying value exceeds the reporting unit’s fair value; however, the loss recognized will not exceed the goodwill allocated to the reporting unit. The adoption of the new accounting rules did not have an impact on the Company’s financial condition, results of operations or cash flows.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

Fair Value

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820),” which modifies the disclosure requirements on fair value measurements. The new accounting rules were effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows; however, its disclosures were updated upon adoption.

Retirement Benefits

In August 2018, the FASB issued ASU 2018-14, “Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20).” The new accounting rules expand disclosure requirements for employer sponsored defined benefit pension and other retirement plans. The new accounting rules were effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows; however, expanded disclosures will be required on the Company’s Annual Report on Form 10-K for the year ended January 2, 2021.

Internal-Use Software

In August 2018, the FASB issued ASU 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 340-40),” which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new accounting rules were effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows.

Codification Improvements to Financial Instruments

In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments.” The new accounting rules clarify guidance around several subtopics by adopting enhanced verbiage to the following subtopics: fair value option disclosures, fair value measurement, investments - debt and equities securities, debt modifications and extinguishments, credit losses, and sales of financial assets. The standard was effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s results of operations or cash flows.

Income Taxes

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” The new accounting rules reduce complexity by removing specific exceptions to general principles related to intraperiod tax allocations, ownership changes in foreign investments, and interim period income tax accounting for year-to-date losses that exceed anticipated losses. The new accounting rules also simplify accounting for franchise taxes that are partially based on income, transactions with a government that result in a step up in the tax basis of goodwill, separate financial statements of legal entities that are not subject to tax, and enacted changes in tax laws in interim periods. The new accounting rules will be effective for the Company in the first quarter of 2021. The Company is currently in the process of evaluating the impact of adoption of the new accounting rules on the Company’s financial condition, results of operations, cash flows and disclosures.

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The new accounting rules provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments in this standard can be applied anytime between the first quarter of 2020 and the fourth quarter of 2022. The Company is currently in the process of evaluating the impact of adoption of the new rules on the Company’s financial condition, results of operations, cash flows and disclosures.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)


(3)	Revenue Recognition

Revenue is recognized when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. Variable consideration includes trade discounts, rebates, volume-based incentives, cooperative advertising and product returns, which are offered within contracts between the Company and its customers, employing the practical expedient for contract costs. Incidental items that are immaterial to the context of the contract are recognized as expense at the transaction date.

The following table presents the Company’s revenues disaggregated by the customer’s method of purchase:



	Quarters Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Third-party brick-and-mortar wholesale	$	1,345,016	$	1,360,994	$	2,323,143	$	2,592,417
Consumer-directed	393,763		399,933		732,098		756,534
Total net sales	$	1,738,779	$	1,760,927	$	3,055,241	$	3,348,951

Revenue Sources

Third-Party Brick-and-Mortar Wholesale Revenue

Third-party brick-and-mortar wholesale revenue is primarily generated by sales of the Company’s products to retailers to support their brick-and-mortar operations. Also included within third-party brick-and-mortar wholesale revenues is royalty revenue from licensing agreements. The Company earns royalties through license agreements with manufacturers of other consumer products that incorporate certain of the Company’s brands. The Company accrues revenue earned under these contracts based upon reported sales from the licensees. Additionally, in the quarter and six months ended June 27, 2020, third-party brick-and-mortar wholesale revenue includes $641,723 of revenue from contracts with governments generated from the sale of both cloth face coverings and gowns for use during the COVID-19 pandemic. Receivables from government contracts of $491,244 are included in “Trade accounts receivable, net” in the Company’s condensed consolidated balance sheet at June 27, 2020.

Consumer-Directed Revenue

Consumer-directed revenue is primarily generated through sales driven directly by the consumer through company-operated stores and e-commerce platforms, which include both owned sites and the sites of the Company’s retail customers.


(4)	Acquisitions

Bras N Things

On February 12, 2018, the Company acquired 100% of the outstanding equity of BNT Holdco Pty Limited (“Bras N Things”) for a total purchase price of A$498,236 (U.S.$391,572). During 2018, due to the final working capital adjustment, the purchase consideration was reduced by A$3,012 (U.S.$2,367), ultimately resulting in a revised purchase price of A$495,224 (U.S.$389,205), which included a cash payment of A$428,956 (U.S.$337,123), an indemnification escrow of A$31,988 (U.S.$25,140) and debt assumed of A$34,280 (U.S.$26,942). U.S. dollar equivalents are based on acquisition date exchange rates.

The Company funded the acquisition with a combination of short-term borrowings under its existing revolving loan facility (the “Revolving Loan Facility”) and cash on hand. During the third quarter of 2019, A$31,425 (U.S.$21,360) of the indemnification escrow, including interest earned, was paid to the sellers. The remaining indemnification escrow, held in one of the Company’s bank accounts, is recognized and classified as restricted cash, with the balance as of June 27, 2020 included in the “Other current assets” line of the Condensed Consolidated Balance Sheet.

Since February 12, 2018, goodwill related to the Bras N Things acquisition decreased by $792 as a result of measurement period adjustments, primarily related to working capital adjustments. The purchase price allocation was finalized in the first quarter of 2019.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)


(5)	Stockholders’ Equity

Basic earnings per share (“EPS”) was computed by dividing net income by the number of weighted average shares of common stock outstanding during the period. Diluted EPS was calculated to give effect to all potentially issuable dilutive shares of common stock using the treasury stock method.

The reconciliation of basic to diluted weighted average shares outstanding is as follows:



	Quarters Ended		Six Months Ended
	June 27, 2020	June 29, 2019	June 27, 2020	June 29, 2019
Basic weighted average shares outstanding	350,538	364,637	354,778	364,603
Effect of potentially dilutive securities:
Stock options	143	480	182	475
Restricted stock units	143	415	165	335
Employee stock purchase plan and other	5	5	8	5
Diluted weighted average shares outstanding	350,829	365,537	355,133	365,418

For the quarter ended June 27, 2020, there were 1,599 restricted stock units excluded from the diluted earnings per share calculation because their effect would be anti-dilutive. For the quarter ended June 29, 2019, there were no anti-dilutive restricted stock units. For the six months ended June 27, 2020 and June 29, 2019, there were 1,330 and 2 restricted stock units excluded from the diluted earnings per share calculation, respectively, because their effect would be anti-dilutive. For the quarters and six months ended June 27, 2020 and June 29, 2019, there were no anti-dilutive stock options to purchase shares of common stock.

On July 28, 2020, the Company’s Board of Directors declared a regular quarterly cash dividend of $0.15 per share on outstanding shares of common stock to be paid on September 1, 2020 to stockholders of record at the close of business on August 11, 2020.

On February 6, 2020, the Company’s Board of Directors approved a new share repurchase program for up to 40,000 shares to be repurchased in open market transactions, subject to market conditions, legal requirements and other factors. Additionally, management has been granted authority to establish a trading plan under Rule 10b5-1 of the Exchange Act in connection with share repurchases, which will allow the Company to repurchase shares in the open market during periods in which the stock trading window is otherwise closed for the Company and certain of the Company’s officers and employees pursuant to the Company’s insider trading policy. Unless terminated earlier by the Company’s Board of Directors, the new program will expire when the Company has repurchased all shares authorized for repurchase under the new program. The new program replaced the Company’s previous share repurchase program for up to 40,000 shares that was originally approved in 2016. For the quarter ended, June 27, 2020, the Company did not enter into any transactions to repurchase shares under the new program. For the six months ended June 27, 2020, the Company entered into transactions to repurchase 14,464 shares at a weighted average repurchase price of $13.83 per share under the new program. The shares were repurchased at a total cost of $200,269. The Company did not repurchase any shares under the previous share repurchase program during 2020 through the expiration of the program on February 6, 2020 or during the quarter or six months ended June 29, 2019. At June 27, 2020, the remaining repurchase authorization under the current share repurchase program totaled 25,536 shares. The primary objective of the share repurchase program is to utilize excess cash to generate shareholder value. Share repurchases are currently prohibited under the Senior Secured Credit Facility.


(6)	Inventories

Inventories consisted of the following:



	June 27, 2020		December 28, 2019		June 29, 2019
Raw materials	$	97,536	$	83,545	$	107,561
Work in process	137,508		136,592		169,509
Finished goods	1,723,399		1,685,708		1,946,129
	$	1,958,443	$	1,905,845	$	2,223,199

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)


(7)	Debt and Notes Payable

Debt and notes payable consisted of the following:



	Interest Rate as of June 27, 2020	Principal Amount				Maturity Date
	Interest Rate as of June 27, 2020	June 27, 2020		December 28, 2019		Maturity Date
Senior Secured Credit Facility:
Revolving Loan Facility	—	$	—	$	—	December 2022
Term Loan A	2.10%	625,000		625,000		December 2022
Term Loan B	1.93%	300,000		300,000		December 2024
Australian Revolving Loan Facility	1.67%	34,345		—		July 2021
5.375% Senior Notes	5.38%	700,000		—		May 2025
4.875% Senior Notes	4.88%	900,000		900,000		May 2026
4.625% Senior Notes	4.63%	900,000		900,000		May 2024
3.5% Senior Notes	3.50%	562,556		558,847		June 2024
European Revolving Loan Facility	1.50%	112,512		110,914		September 2020
Accounts Receivable Securitization Facility	—	—		—		March 2021
Total debt		4,134,413		3,394,761
Notes payable		8,803		4,244
Total debt and notes payable		4,143,216		3,399,005
Less long-term debt issuance costs		36,270		26,977
Less notes payable		8,803		4,244
Less current maturities		112,512		110,914
Total long-term debt		$	3,985,631	$	3,256,870

As of June 27, 2020, the Company had $957,718 of borrowing availability under the $1,000,000 Revolving Loan Facility after taking into account $42,282 of standby and trade letters of credit issued and outstanding under this facility. In March 2020, in response to the uncertainty of the circumstances surrounding the COVID-19 pandemic, the Company drew down $630,000 under the Revolving Loan Facility as a precautionary measure to provide the Company with additional financial flexibility to manage its business with a safety-first emphasis during the unknown duration and impact of the COVID-19 pandemic. The Company subsequently repaid $490,000 of its borrowings under the Revolving Loan Facility in April 2020. The remaining outstanding balance on the Revolving Loan Facility was repaid in connection with the issuance of the 5.375% Senior Notes in May 2020 discussed below.

The Company entered into an accounts receivable securitization facility (the “Accounts Receivable Securitization Facility”) in November 2007. The Company’s maximum borrowing capacity under the Accounts Receivable Securitization Facility was $175,000 as of June 27, 2020. Borrowings under the Accounts Receivable Securitization Facility are permitted only to the extent that the face of the receivables in the collateral pool, net of applicable reserves and other deductions, exceeds the outstanding loans and also subject to a fluctuating facility limit, not to exceed $225,000. The Company had $81,868 borrowing availability under the Accounts Receivable Securitization Facility at June 27, 2020.

The Company had $6,869 of borrowing availability under the Australian Revolving Loan Facility, no borrowing availability under the European Revolving Loan Facility and $112,458 of borrowing availability under other international credit facilities after taking into account outstanding borrowings and letters of credit outstanding under the applicable facilities at June 27, 2020.

In March 2020, the Company amended the Accounts Receivable Securitization Facility. This amendment primarily decreased the fluctuating facility limit to $225,000 (previously $300,000) and extended the maturity date to March 2021. As a result of the COVID-19 pandemic, in May 2020, the Company amended the Accounts Receivable Securitization Facility which changed certain ratios, inserted a floor and raised pricing, as well as removed certain receivables from being pledged as collateral for the facility, increased limits on other receivables pledged as collateral and required the Company to maintain the same minimum liquidity covenant contained in the Senior Secured Credit Facility.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

In May 2020, the Company issued $700,000 aggregate principal amount of 5.375% Senior Notes, with interest payable on May 15 and November 15 of each year commencing on November 15, 2020. The 5.375% Senior Notes will mature on May 15, 2025. The sale of the 5.375% Senior Notes resulted in net proceeds of $691,250 which were used to repay all outstanding borrowings under its Revolving Loan Facility, pay related fees and expenses, and for general corporate purposes. The issuance of the 5.375% Senior Notes resulted in $12,223 of capitalized debt issuance costs. Debt issuance costs are amortized to interest expense over the life of the debt instrument.

On and after May 15, 2022, the Company has the right to redeem all or a portion of the 5.375% Senior Notes, at the redemption prices set forth in the indenture governing the 5.375% Senior Notes, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

Prior to May 15, 2022, the Company has the right to redeem all or of a portion of the 5.375% Senior Notes at a redemption price equal to 100% of the principal amount plus a “make-whole” premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, prior to May 15, 2022, the Company may on any one or more occasions redeem up to 40% of the notes with the net proceeds from certain equity offerings at a redemption price equal to 105.375% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

The 5.375% Senior Notes are senior unsecured obligations of the Company and are fully and unconditionally guaranteed by the Company and each of its domestic subsidiaries that guarantee the Company’s Senior Secured Credit Facility. The indenture governing the 5.375% Senior Notes includes covenants that limit the ability of the Company and its subsidiaries to incur certain liens, enter into certain sale and leaseback transactions and the ability of the Company and the guarantors to consolidate, merge or sell all or substantially all of their assets. The indenture also contains customary events of default which include (subject in certain cases to customary grace and cure periods), among others, nonpayment of principal or interest; breach of other agreements in the indenture; failure to pay certain other indebtedness; certain events of bankruptcy, insolvency or reorganization; failure to pay certain final judgments; and failure of certain guarantees to be enforceable.

In the event of a change of control of the Company and a rating downgrade, the Company will be required to offer to repurchase all outstanding 5.375% Senior Notes at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date.

The 5.375% Senior Notes were issued in a transaction exempt from registration under the Securities Act and do not require disclosure of separate financial information for the guarantor subsidiaries.

As of June 27, 2020, the Company was in compliance with all financial covenants under its credit facilities and other outstanding indebtedness. The Company continues to monitor its covenant compliance. Under the terms of its Senior Secured Credit Facility, among other financial and non-financial covenants, the Company is required to maintain a minimum interest coverage ratio and a maximum leverage ratio. The interest coverage ratio covenant is the ratio of the Company’s EBITDA for the preceding four fiscal quarters to its consolidated total interest expense and the maximum leverage ratio covenant is the ratio of the Company’s net debt to EBITDA for the preceding four fiscal quarters. EBITDA is defined as earnings before interest, income taxes, depreciation expense and amortization, as computed pursuant to the Senior Secured Credit Facility.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 pandemic and the associated impact on future earnings, the Company amended its Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. The amendment effects changes to certain provisions and covenants under the Senior Secured Credit Facility during the period beginning with the fiscal quarter ended June 27, 2020 and continuing through the fiscal quarter ending July 3, 2021 (such period of time, the “Covenant Relief Period”), including: (a) suspension of compliance with the maximum leverage ratio; (b) reduction of the minimum interest coverage ratio from 3.00 to 1.00 to (i) 2.00 to 1.00 for the fiscal quarters ending June 27, 2020 through April 3, 2021 and (ii) 2.25 to 1.00 for the fiscal quarter ending July 3, 2021; (c) a minimum last twelve months EBITDA covenant of $625,000 as of June 27, 2020, $505,000 as of September 26, 2020, $445,000 as of January 2, 2021, $435,000 as of April 3, 2021 and $505,000 as of July 3, 2021; (d) a minimum liquidity covenant of $300,000, increasing to $400,000 upon certain conditions; (e) increased limitations on investments, acquisitions, restricted payments and the incurrence of indebtedness; and (f) anti-cash hoarding provisions. During the Covenant Relief Period, the applicable margin and applicable commitment fee margin will be calculated assuming the leverage ratio is greater than or equal to 4.50 to 1.00. The amendment also permanently amends the definition of “leverage ratio” for purposes of the financial covenant calculation to remove the maximum amount of cash allowed to be netted from the definition of “indebtedness” and to allow for the netting of cash from certain foreign subsidiaries. After obtaining the debt amendment, the Company expects to maintain compliance with its covenants for at least one year from the date of these financial statements based on its current expectations and forecasts. If economic conditions caused by the COVID-19 pandemic worsen and the Company’s earnings and operating cash flows do not start to recover as currently estimated by management, this could impact the Company’s ability to maintain compliance with its amended financial covenants and require the Company to seek additional amendments to its Senior Secured Credit Facility. If the Company is not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, its lenders could require the Company to repay its outstanding debt. In that situation, the Company may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders.


(8)	Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss (“AOCI”) are as follows:



	Cumulative Translation Adjustment⁽¹⁾			Cash Flow Hedges			Defined Benefit Plans			Income Taxes			Accumulated Other Comprehensive Loss
Balance at December 28, 2019	$	(157,138	)	$	4,786		$	(629,360	)	$	164,064		$	(617,648	)
Amounts reclassified from accumulated other comprehensive loss	—			(8,174		)	10,289			(416		)	1,699
Current-period other comprehensive income (loss) activity	(22,121		)	13,029			(69		)	(5,899		)	(15,060		)
Total other comprehensive income (loss)	(22,121		)	4,855			10,220			(6,315		)	(13,361		)

Balance at June 27, 2020	$	(179,259	)	$	9,641		$	(619,140	)	$	157,749		$	(631,009	)


(1)	Cumulative Translation Adjustment includes translation adjustments and net investment hedges. See Note, “Financial Instruments and Risk Management” for additional disclosures about net investment hedges.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

The Company had the following reclassifications out of AOCI:



Component of AOCI	Location of Reclassification into Income	Amount of Reclassification from AOCI
		Quarters Ended						Six Months Ended
		June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Gain on foreign exchange contracts designated as cash flow hedges	Cost of sales	$	3,157		$	8,347		$	8,174		$	14,364
	Income tax	(802		)	(1,887		)	(2,074		)	(3,408		)
	Net of tax	2,355			6,460			6,100			10,956
Amortization of deferred actuarial loss and prior service cost	Other expenses	(5,423		)	(4,964		)	(10,289		)	(9,566		)
	Income tax	1,218			1,411			2,490			2,616
	Net of tax	(4,205		)	(3,553		)	(7,799		)	(6,950		)

Total reclassifications		$	(1,850	)	$	2,907		$	(1,699	)	$	4,006


(9)	Financial Instruments and Risk Management

The Company uses forward foreign exchange contracts to manage its exposures to movements in foreign exchange rates. The Company also uses a combination of derivative instruments and long-term debt to manage its exposure to foreign currency risk associated with the Company’s net investment in its European subsidiaries.

As of June 27, 2020, the notional U.S. dollar equivalent of the Company’s derivative portfolio of forward foreign exchange contracts was $552,967, consisting of contracts hedging exposures primarily related to the Australian dollar, Euro, Canadian dollar and Mexican peso. As of June 27, 2020, the U.S. dollar equivalent carrying value of long-term debt designated as a partial European net investment hedge was $562,556. The notional U.S. dollar equivalent of the Company’s cross-currency swap contracts, which are also designated as partial European net investment hedges, was $335,940 as of June 27, 2020.

Fair Values of Derivative Instruments

The fair values of derivative financial instruments related to forward foreign exchange contracts and cross-currency swap contracts recognized in the Condensed Consolidated Balance Sheets of the Company were as follows:



	Balance Sheet Location	Fair Value
	Balance Sheet Location	June 27, 2020			December 28, 2019
Derivatives designated as hedging instruments:
Forward foreign exchange contracts	Other current assets	$	3,231		$	2,716
Cross-currency swap contracts	Other current assets	901			926
Cross-currency swap contracts	Other noncurrent assets	17,509			2,975
Derivatives not designated as hedging instruments:
Forward foreign exchange contracts	Other current assets	3,926			5,314
Total derivative assets		25,567			11,931

Derivatives designated as hedging instruments:
Forward foreign exchange contracts	Accrued liabilities	(1,129		)	(2,246		)
Derivatives not designated as hedging instruments:
Forward foreign exchange contracts	Accrued liabilities	(1,344		)	(1,147		)
Total derivative liabilities		(2,473		)	(3,393		)

Net derivative asset		$	23,094		$	8,538

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

Cash Flow Hedges

The Company uses forward foreign exchange contracts to reduce the effect of fluctuating foreign currencies on short-term foreign currency-denominated transactions, foreign currency-denominated investments and other known foreign currency exposures. Gains and losses on these contracts are intended to offset losses and gains on the hedged transaction in an effort to reduce the earnings volatility resulting from fluctuating foreign currency exchange rates.

The Company expects to reclassify into earnings during the next 12 months a net gain from AOCI of approximately $9,961. The Company is hedging exposure to the variability in future cash flows for forecasted transactions over the next 17 months.

The effect of cash flow hedge derivative instruments on the Condensed Consolidated Statements of Income and AOCI is as follows:



	Amount of Gain (Loss) Recognized in AOCI on Derivative Instruments
	Quarters Ended					Six Months Ended
	June 27, 2020			June 29, 2019		June 27, 2020		June 29, 2019
Foreign exchange contracts	$	(7,051	)	$	1,274	$	13,029	$	1,714



	Location of Gain Reclassified from AOCI into Income	Amount of Gain Reclassified from AOCI into Income
		Quarters Ended				Six Months Ended
		June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Foreign exchange contracts⁽¹⁾	Cost of sales	$	3,157	$	8,347	$	8,174	$	14,364


(1)	The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value.



	Quarters Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Total cost of sales in which the effects of cash flow hedges are recorded	$	1,105,767	$	1,085,404	$	1,948,497	$	2,053,397

Net Investment Hedges

In July 2019, the Company entered into two pay-fixed rate, receive-fixed rate cross-currency swap contracts with a total notional amount of €300,000 that were designated as hedges of a portion of the beginning balance of the Company’s net investment in its European subsidiaries. These cross-currency swap contracts, which mature on May 15, 2024, swap U.S. dollar-denominated interest payments for Euro-denominated interest payments, thereby economically converting a portion of the Company’s fixed-rate 4.625% Senior Notes to a fixed-rate 2.3215% Euro-denominated obligation.

In July 2019, the Company also designated its 3.5% Senior Notes with a carrying value of €500,000, which is a nonderivative financial instrument, as a hedge of a portion of the beginning balance of the Company’s European net investment.

The amount of after-tax gains (losses) included in AOCI in the Condensed Consolidated Balance Sheets related to derivative instruments and nonderivative financial instruments designated as net investment hedges and the amount of gains included in the “Interest expense, net” line in the Condensed Consolidated Statements of Income related to amounts excluded from the assessment of hedge effectiveness for derivative instruments designated as net investment hedges are as follows:



	Amount of Gain (Loss) Recognized in AOCI
	Quarters Ended					Six Months Ended
	June 27, 2020			June 29, 2019		June 27, 2020			June 29, 2019
Euro-denominated long-term debt	$	(4,196	)	$	—	$	(1,538	)	$	—
Cross-currency swap contracts	(1,004		)	—		10,728			—
Total	$	(5,200	)	$	—	$	9,190		$	—

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)



	Location of Gain Recognized in Income	Amount of Gain Recognized in Income (Amount Excluded from Effectiveness Testing)
		Quarters Ended				Six Months Ended
		June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Cross-currency swap contracts	Interest expense, net	$	2,020	$	—	$	3,967	$	—


		Quarters Ended				Six Months Ended
		June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Total interest expense, net in which the amounts excluded from effectiveness testing for net investment hedges are recorded		$	41,659	$	46,522	$	78,508	$	94,581

Mark to Market Hedges

A derivative used as a hedging instrument whose change in fair value is recognized to act as a hedge against changes in the values of the hedged item is designated as a mark to market hedge. The Company uses foreign exchange derivative contracts as hedges against the impact of foreign exchange fluctuations on existing accounts receivable and payable balances and intercompany lending transactions denominated in foreign currencies. Foreign exchange derivative contracts are recorded as mark to market hedges when the hedged item is a recorded asset or liability that is revalued in each accounting period. These contracts are not designated as hedges under the accounting standards and are recorded at fair value in the Condensed Consolidated Balance Sheets. Any gains or losses resulting from changes in fair value are recognized directly into earnings. Gains or losses on these contracts largely offset the net remeasurement gains or losses on the related assets and liabilities.

The effect of derivative contracts not designated as hedges on the Condensed Consolidated Statements of Income is as follows:



	Location of Gain (Loss) Recognized in Income on Derivatives	Amount of Gain (Loss) Recognized in Income
		Quarters Ended						Six Months Ended
		June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Foreign exchange contracts	Cost of sales	$	(19,104	)	$	(9,361	)	$	(12,983	)	$	(18,758	)
Foreign exchange contracts	Selling, general and administrative expenses	1,959			(262		)	928			(921		)
Total		$	(17,145	)	$	(9,623	)	$	(12,055	)	$	(19,679	)


(10)	Fair Value of Assets and Liabilities

As of June 27, 2020, the Company held certain financial assets and liabilities that are required to be measured at fair value on a recurring basis. These consisted of the Company’s derivative instruments related to forward foreign exchange derivative contracts, cross-currency swap derivative contracts and deferred compensation plan liabilities. The fair values of forward foreign exchange derivative contracts are determined using the cash flows of the forward contracts, discount rates to account for the passage of time and current foreign exchange market data which are all based on inputs readily available in public markets and are categorized as Level 2. The fair values of cross-currency swap derivative contracts are determined using the cash flows of the swap contracts, discount rates to account for the passage of time, current foreign exchange and interest rate market data and credit risk, which are all based on inputs readily available in public markets and are categorized as Level 2. The fair value of deferred compensation plans is based on readily available current market data and is categorized as Level 2. The Company’s defined benefit pension plan investments are not required to be measured at fair value on a quarterly recurring basis.

There were no changes during the quarter and six months ended June 27, 2020 to the Company’s valuation techniques used to measure asset and liability fair values on a recurring basis. As of and during the quarter and six months ended June 27, 2020, the Company did not have any non-financial assets or liabilities that were required to be measured at fair value on a recurring or non-recurring basis.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities accounted for at fair value on a recurring basis.



	Assets (Liabilities) at Fair Value as of June 27, 2020
	Total			Quoted Prices In Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Forward foreign exchange contracts - assets	$	7,157		$	—	$	7,157		$	—
Cross-currency swap contracts - assets	18,410			—		18,410			—
Forward foreign exchange contracts - liabilities	(2,473		)	—		(2,473		)	—
	23,094			—		23,094			—
Deferred compensation plan liability	(18,907		)	—		(18,907		)	—
Total	$	4,187		$	—	$	4,187		$	—



	Assets (Liabilities) at Fair Value as of December 28, 2019
	Total			Quoted Prices In Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Forward foreign exchange contracts - assets	$	8,030		$	—	$	8,030		$	—
Cross-currency swap contracts - assets	3,901			—		3,901			—
Forward foreign exchange contracts - liabilities	(3,393		)	—		(3,393		)	—
	8,538			—		8,538			—
Deferred compensation plan liability	(31,221		)	—		(31,221		)	—
Total	$	(22,683	)	$	—	$	(22,683	)	$	—

Fair Value of Financial Instruments

The carrying amounts of cash and cash equivalents, trade accounts receivable, notes receivable and accounts payable approximated fair value as of June 27, 2020 and December 28, 2019. The carrying amount of trade accounts receivable included allowance for doubtful accounts, chargebacks and other deductions of $48,197 and $33,228 as of June 27, 2020 and December 28, 2019, respectively. The fair value of debt, which is classified as a Level 2 liability, was $4,175,552 and $3,560,623 as of June 27, 2020 and December 28, 2019, respectively. Debt had a carrying value of $4,134,413 and $3,394,761 as of June 27, 2020 and December 28, 2019, respectively. The fair values were estimated using quoted market prices as provided in secondary markets, which consider the Company’s credit risk and market related conditions. The carrying amount of the Company’s notes payable, which is classified as a Level 2 liability, approximated fair value as of June 27, 2020 and December 28, 2019, primarily due to the short-term nature of these instruments.


(11)	Income Taxes

The Company’s effective income tax rate was 17.3% and 14.5% for the quarters ended June 27, 2020 and June 29, 2019, respectively. The Company’s effective income tax rate was 17.4% and 14.2% for the six months ended June 27, 2020 and June 29, 2019, respectively. The higher effective tax rate for the quarter and six months ended June 27, 2020 was primarily due to the change in jurisdictional mix of income attributable to the economic impacts of COVID-19.

During the six months ended June 27, 2020, the Internal Revenue Service closed the examination of the income tax years ended January 2, 2016 and December 31, 2016. The examination resulted in an immaterial adjustment which had been accrued as an uncertain tax benefit in a prior period. The Company remains subject to examinations in other jurisdictions and believes that it maintains appropriate uncertain tax benefit reserves, which are re-evaluated each quarter. Management believes it is reasonably possible that the amount of uncertain tax benefits may decrease by approximately $25,362 in the next 12 months based on approvals of certain filings by tax authorities with approximately $15,306 of the reduction impacting the effective tax rate.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)

As a result of the COVID-19 pandemic, governments are offering various relief mechanisms to taxpayers to assist with the business disruption. The measures vary by jurisdiction, but often include the ability to delay certain income tax payments. The Company intends to use these provisions where eligible. As of June 27, 2020, the Company does not expect the COVID-19 relief measures to have a material impact on its financial results, including on its annual estimated effective tax rate or on liquidity.


(12)	Business Segment Information

The Company’s operations are managed and reported in three operating segments, each of which is a reportable segment for financial reporting purposes: Innerwear, Activewear and International. These segments are organized principally by product category and geographic location. Each segment has its own management team that is responsible for the operations of the segment’s businesses, but the segments share a common supply chain and media and marketing platforms. Other consists of the Company’s U.S.-based outlet stores and U.S. hosiery business.

The types of products and services from which each reportable segment derives its revenues are as follows:


•	Innerwear includes sales of basic branded apparel products that are replenishment in nature under the product categories of men’s underwear, women’s panties, children’s underwear and socks, and intimate apparel, which includes bras and shapewear. Beginning in 2020, Innerwear also includes sales of PPE including products such as cloth face coverings and gowns.


•	Activewear includes sales of basic branded products that are primarily seasonal in nature to both retailers and wholesalers, as well as licensed sports apparel and licensed logo apparel in collegiate bookstores, mass retailers and other channels.


•	International includes sales of products in all of the Company’s categories, including PPE in 2020, outside the United States, primarily in Europe, Australia, Asia, Latin America and Canada.

The Company evaluates the operating performance of its segments based upon segment operating profit, which is defined as operating profit before general corporate expenses, restructuring and other action-related charges and amortization of intangibles. The accounting policies of the segments are consistent with those described in Note, “Summary of Significant Accounting Policies” to the Company’s consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 28, 2019.



	Quarters Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net sales:
Innerwear	$	1,094,814	$	678,604	$	1,517,216	$	1,154,549
Activewear	168,379		448,277		456,379		853,617
International	456,875		568,863		1,012,776		1,215,043
Other	18,711		65,183		68,870		125,742
Total net sales	$	1,738,779	$	1,760,927	$	3,055,241	$	3,348,951

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)



	Quarters Ended						Six Months Ended
	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Segment operating profit:
Innerwear	$	304,524		$	149,530		$	386,075		$	254,156
Activewear	(5,751		)	68,779			2,357			112,372
International	79,124			81,078			131,142			180,851
Other	(12,270		)	6,032			(18,395		)	6,786
Total segment operating profit	365,627			305,419			501,179			554,165
Items not included in segment operating profit:
General corporate expenses	(52,079		)	(54,990		)	(115,712		)	(123,339		)
Restructuring and other action-related charges	(63,296		)	(12,609		)	(92,495		)	(33,982		)
Amortization of intangibles	(8,716		)	(8,220		)	(17,306		)	(17,600		)
Total operating profit	241,536			229,600			275,666			379,244
Other expenses	(5,050		)	(8,249		)	(11,540		)	(15,700		)
Interest expense, net	(41,659		)	(46,522		)	(78,508		)	(94,581		)
Income before income tax expense	$	194,827		$	174,829		$	185,618		$	268,963

For the quarter ended June 27, 2020, the Company incurred pre-tax restructuring and other action-related charges of $63,296, of which $26,534 is reported in the “Cost of sales” line and $36,762 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. For the quarter ended June 29, 2019, the Company incurred pre-tax restructuring and other action-related charges of $12,609, of which $12,598 is reported in the “Cost of sales” line and $11 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income.

For the six months ended June 27, 2020, the Company incurred pre-tax acquisition, integration and other action-related charges of $92,495, of which $48,347 is reported in the “Cost of sales” line and $44,148 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. For the six months ended June 29, 2019, the Company incurred pre-tax acquisition-related, integration and other action-related charges of $33,982, of which $30,290 is reported in the “Cost of sales” line and $3,692 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income.

As of December 28, 2019, the Company had an accrual of $7,120 for expected benefit payments related to actions taken in prior years. During the six months ended June 27, 2020, the Company approved actions related to workforce reductions and incurred charges of $8,538 for employee termination and other benefits for employees affected by separation programs with $2,500 and $6,038 of charges reflected in the “Cost of sales” and “Selling, general and administrative expenses” lines, respectively, in the Consolidated Statement of Income. During the six months ended June 27, 2020, benefit payments, other accrual adjustments and foreign currency adjustments of $5,687 have been made, resulting in an ending accrual of $9,971, of which $8,911 and $1,060 is included in the “Accrued liabilities” and “Other noncurrent liabilities” lines of the Condensed Consolidated Balance Sheet, respectively.

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)


(13)	Revisions of Previously Issued Condensed Consolidated Interim Financial Statements

As described in Note, "Basis of Presentation," the following tables set forth the impact of error corrections on the Company’s condensed consolidated interim financial statements as of and for the periods ended June 29, 2019 and September 28, 2019 by financial statement line item.



	Quarter Ended June 29, 2019
Condensed Consolidated Statement of Income Line Item	As Previously Reported		Adjustments			As Revised
Cost of sales	$	1,086,248	$	(844	)	$	1,085,404
Gross profit	674,679		844			675,523
Selling, general and administrative expenses	440,662		5,261			445,923
Operating profit	234,017		(4,417		)	229,600
Income before income tax expense	179,246		(4,417		)	174,829
Net income	153,972		(4,417		)	149,555

Earnings per share:
Basic	$	0.42	$	(0.01	)	$	0.41
Diluted	$	0.42	$	(0.01	)	$	0.41



	Six Months Ended June 29, 2019
Condensed Consolidated Statement of Income Line Item	As Previously Reported		Adjustments			As Revised
Cost of sales	$	2,053,396	$	1		$	2,053,397
Gross profit	1,295,555		(1		)	1,295,554
Selling, general and administrative expenses	913,500		2,810			916,310
Operating profit	382,055		(2,811		)	379,244
Income before income tax expense	271,774		(2,811		)	268,963
Net income	233,454		(2,811		)	230,643

Earnings per share:
Basic	$	0.64	$	(0.01	)	$	0.63
Diluted	$	0.64	$	(0.01	)	$	0.63



	Quarter Ended June 29, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item	As Previously Reported		Adjustments			As Revised
Net income	$	153,972	$	(4,417	)	$	149,555
Comprehensive income	149,165		(4,417		)	144,748



	Six Months Ended June 29, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item	As Previously Reported		Adjustments			As Revised
Net income	$	233,454	$	(2,811	)	$	230,643
Translation adjustments	11,259		(7,075		)	4,184
Total other comprehensive income	9,132		(7,075		)	2,057
Comprehensive income	242,586		(9,886		)	232,700

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)



	June 29, 2019
Condensed Consolidated Balance Sheet Line Item	As Previously Reported		Adjustments			As Revised
Inventories	$	2,233,760	$	(10,561	)	$	2,223,199
Other current assets	152,925		23,371			176,296
Total current assets	3,656,442		12,810			3,669,252
Deferred tax assets	264,592		(43,665		)	220,927
Total assets	7,876,892		(30,855		)	7,846,037
Accrued liabilities	547,306		13,866			561,172
Total current liabilities	2,069,817		13,866			2,083,683
Other noncurrent liabilities	277,742		64,743			342,485
Total liabilities	6,742,042		78,609			6,820,651
Retained earnings	1,395,306		(109,464		)	1,285,842
Total stockholders’ equity	1,134,850		(109,464		)	1,025,386
Total liabilities and stockholders’ equity	7,876,892		(30,855		)	7,846,037



	Quarter Ended June 29, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item	As Previously Reported		Adjustments			As Revised
Balance at March 30, 2019	$	1,038,038	$	(105,047	)	$	932,991
Net income	153,972		(4,417		)	149,555
Balance at June 29, 2019	1,134,850		(109,464		)	1,025,386



	Six Months Ended June 29, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item	As Previously Reported		Adjustments			As Revised
Balance at December 29, 2018	$	970,283	$	(98,157	)	$	872,126
Net income	233,454		(2,811		)	230,643
Other comprehensive income	9,132		(7,075		)	2,057
Cumulative effect of change in adoption of leases standard	7,977		(1,421		)	6,556
Balance at June 29, 2019	1,134,850		(109,464		)	1,025,386



	Six Months Ended June 29, 2019
Condensed Consolidated Statement of Cash Flows Line Item	As Previously Reported			Adjustments			As Revised
Operating activities:
Net income	$	233,454		$	(2,811	)	$	230,643
Adjustments to reconcile net income to net cash from operating activities:
Other	12,550			(7,075		)	5,475
Changes in assets and liabilities:
Inventories	(178,453		)	12,941			(165,512		)
Other assets	(27,354		)	(1,225		)	(28,579		)
Accrued liabilities and other	(23,405		)	(1,830		)	(25,235		)
Net cash from operating activities	(57,363		)	—			(57,363		)

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)



	Quarter Ended September 28, 2019
Condensed Consolidated Statement of Income Line Item	As Previously Reported		Adjustments			As Revised
Cost of sales	$	1,154,629	$	(4,695	)	$	1,149,934
Gross profit	712,338		4,695			717,033
Selling, general and administrative expenses	442,582		7,380			449,962
Operating profit	269,756		(2,685		)	267,071
Income before income tax expense	218,599		(2,685		)	215,914
Net income	187,776		(2,685		)	185,091

Earnings per share:
Basic	$	0.51	$	(0.01	)	$	0.51
Diluted	$	0.51	$	(0.01	)	$	0.51



	Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Income Line Item	As Previously Reported		Adjustments			As Revised
Cost of sales	$	3,208,025	$	(4,694	)	$	3,203,331
Gross profit	2,007,893		4,694			2,012,587
Selling, general and administrative expenses	1,356,082		10,190			1,366,272
Operating profit	651,811		(5,496		)	646,315
Income before income tax expense	490,373		(5,496		)	484,877
Net income	421,230		(5,496		)	415,734

Earnings per share:
Basic	$	1.16	$	(0.02	)	$	1.14
Diluted	$	1.15	$	(0.02	)	$	1.14



	Quarter Ended September 28, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item	As Previously Reported		Adjustments			As Revised
Net income	$	187,776	$	(2,685	)	$	185,091
Comprehensive income	148,443		(2,685		)	145,758



	Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item	As Previously Reported			Adjustments			As Revised
Net income	$	421,230		$	(5,496	)	$	415,734
Translation adjustments	(33,738		)	(7,075		)	(40,813		)
Total other comprehensive loss	(30,201		)	(7,075		)	(37,276		)
Comprehensive income	391,029			(12,571		)	378,458

Table of Contents

HANESBRANDS INC.

Notes to Condensed Consolidated Financial Statements — (Continued)

(amounts in thousands, except per share data)

(unaudited)



	September 28, 2019
Condensed Consolidated Balance Sheet Line Item	As Previously Reported		Adjustments			As Revised
Inventories	$	2,108,281	$	(13,246	)	$	2,095,035
Other current assets	166,727		7,445			174,172
Total current assets	3,625,970		(5,801		)	3,620,169
Deferred tax assets	257,314		(43,665		)	213,649
Total assets	7,773,298		(49,466		)	7,723,832
Accrued liabilities	589,992		(2,060		)	587,932
Total current liabilities	2,096,904		(2,060		)	2,094,844
Other noncurrent liabilities	265,804		64,743			330,547
Total liabilities	6,543,056		62,683			6,605,739
Retained earnings	1,528,258		(112,149		)	1,416,109
Total stockholders’ equity	1,230,242		(112,149		)	1,118,093
Total liabilities and stockholders’ equity	7,773,298		(49,466		)	7,723,832



	Quarter Ended September 28, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item	As Previously Reported		Adjustments			As Revised
Balance at June 29, 2019	$	1,134,850	$	(109,464	)	$	1,025,386
Net income	187,776		(2,685		)	185,091
Balance at September 28, 2019	1,230,242		(112,149		)	1,118,093



	Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item	As Previously Reported			Adjustments			As Revised
Balance at December 29, 2018	$	970,283		$	(98,157	)	$	872,126
Net income	421,230			(5,496		)	415,734
Other comprehensive income	(30,201		)	(7,075		)	(37,276		)
Cumulative effect of change in adoption of leases standard	7,977			(1,421		)	6,556
Balance at September 28, 2019	1,230,242			(112,149		)	1,118,093



	Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Cash Flows Line Item	As Previously Reported			Adjustments			As Revised
Operating activities:
Net income	$	421,230		$	(5,496	)	$	415,734
Adjustments to reconcile net income to net cash from operating activities:
Other	8,737			(7,075		)	1,662
Changes in assets and liabilities, net of acquisition of businesses:
Inventories	(72,096		)	15,626			(56,470		)
Other assets	(40,732		)	14,701			(26,031		)
Accrued liabilities and other	14,243			(17,756		)	(3,513		)
Net cash from operating activities	244,700			—			244,700

Table of Contents



Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations

This management’s discussion and analysis of financial condition and results of operations, or MD&A, contains forward-looking statements that involve risks and uncertainties. Please see “Forward-Looking Statements” in this Quarterly Report on Form 10-Q for a discussion of the uncertainties, risks and assumptions associated with these statements. This discussion should be read in conjunction with our historical financial statements and related notes thereto and the other disclosures contained elsewhere in this Quarterly Report on Form 10-Q. The unaudited condensed interim consolidated financial statements and notes included herein should be read in conjunction with our audited consolidated financial statements and notes for the year ended December 28, 2019, which were included in our Annual Report on Form 10-K filed with the SEC. The results of operations for the periods reflected herein are not necessarily indicative of results that may be expected for future periods, and our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including but not limited to those included elsewhere in this Quarterly Report on Form 10-Q and those included in the “Risk Factors” section and elsewhere in our Annual Report on Form 10-K for the year ended December 28, 2019 and in our Quarterly Report on Form 10-Q for the quarter ended March 28, 2020. In particular, statements with respect to trends associated with our business, our future financial performance and the potential effects of the global COVID-19 pandemic included in this Quarterly Report on Form 10-Q specifically appearing under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” include forward-looking statements. The unaudited condensed consolidated interim financial statements for the quarter and six months ended June 29, 2019 have been revised to correct prior period errors as discussed in Note, “Basis of Presentation” and Note, “Revisions of Previously Issued Condensed Consolidated Interim Financial Statements” to our unaudited condensed consolidated interim financial statements included in this Quarterly Report on Form 10-Q. Accordingly, this MD&A reflects the impact of those revisions.

Overview

Hanesbrands Inc. (collectively with its subsidiaries, “we,” “us,” “our,” or the “Company”) is a socially responsible leading marketer of everyday basic innerwear and activewear apparel in the Americas, Europe, Australia and Asia/Pacific under some of the world’s strongest apparel brands, including Hanes, Champion, Bonds, DIM, Maidenform, Bali, Playtex, Lovable, Bras N Things, Nur Die/Nur Der, Alternative, L’eggs, JMS/Just My Size, Wonderbra, Berlei and Gear for Sports. We design, manufacture, source and sell a broad range of basic apparel such as T-shirts, bras, panties, shapewear, underwear, socks, hosiery and activewear, produced in our low-cost global supply chain. Our brands hold either the number one or number two market position by units sold in many of the product categories and geographies in which we compete.

Our operations are managed and reported in three operating segments, each of which is a reportable segment for financial reporting purposes: Innerwear, Activewear and International. These segments are organized principally by product category and geographic location. Each segment has its own management team that is responsible for the operations of the segment’s businesses, but the segments share a common supply chain and media and marketing platforms. Other consists of our U.S.-based outlet stores and U.S. hosiery business.

Impact of COVID-19 on Our Business

On March 11, 2020, the World Health Organization declared the novel strain of coronavirus (COVID-19) a global pandemic and recommended containment and mitigation measures worldwide. The pandemic and these containment and mitigation measures have led to adverse impacts on the U.S. and global economies. The COVID-19 pandemic has impacted our business operations and results of operations for the second quarter and six months of 2020 as described in more detail under “Condensed Consolidated Results of Operations - Second Quarter Ended June 27, 2020 Compared with Second Quarter Ended June 29, 2019” and “Condensed Consolidated Results of Operations - Six Months Ended June 27, 2020 Compared with Six Months Ended June 29, 2019” below, due to decreased customer traffic and temporary retail store closures worldwide. The evolving COVID-19 pandemic could continue to have an adverse impact on our results of operations and liquidity; the operations of our suppliers, vendors and customers; and on our employees as a result of quarantines, facility closures, and travel and other restrictions. While the ultimate global and economic impact of the COVID-19 pandemic remains highly uncertain, we expect that our business operations and results of operations, including our net sales, earnings and cash flows, will be materially impacted for at least the balance of 2020, as a result of:


•	decreased customer traffic in our retail stores and retail stores in which our products are sold;


•	changes in consumer confidence and consumer spending habits, including spending for the merchandise that we sell and negative trends in consumer purchasing patterns due to changes in consumers’ disposable income, credit availability and debt levels;


•	decreased discretionary consumer-directed channel spending independent of store closures;

Table of Contents


•	decreased wholesale channel sales and increased likelihood of wholesale customer financial distress, including requests for extended payment terms or potential payment defaults;


•	disruption to our global supply chain including the manufacturing, supply, distribution, transportation and delivery of our products;


•	decreased productivity due to travel bans, work-from-home policies or shelter-in-place orders; and


•	a slowdown in the U.S. and global economies, and an uncertain global economic outlook or a potential credit crisis.

The extent to which the COVID-19 pandemic impacts our business operations, financial results, and liquidity will depend on numerous evolving factors that we may not be able to accurately predict or assess, including the duration and scope of the pandemic; our response to and ability to respond to and adjust our business strategies to mitigate the impact of the pandemic; the negative impact it has on global and regional economies and economic activity, including the duration and magnitude of its impact on unemployment rates and consumer discretionary spending; its short- and longer-term impact on the levels of consumer confidence; the ability of our suppliers, vendors and customers to successfully address the impacts of the pandemic; actions governments, businesses and individuals take in response to the pandemic; and how quickly economies recover after the COVID-19 pandemic subsides.

We expect the negative impact of the COVID-19 pandemic to lead to continued net sales decreases due to decreased traffic at our retail stores and reduced net sales and earnings for our wholesale customers, some of which have experienced or may experience financial distress or declare bankruptcy. Reduced retail sales or additional customer store closures and customer bankruptcies could reduce or eliminate our anticipated income and cash flows, which would negatively affect our results of operations and liquidity. Even if customers do not declare bankruptcy, some have extended payment terms and more may seek to extend payment terms or be unable or unwilling to pay us amounts that we are entitled to on a timely basis or at all, which would adversely affect our earnings and liquidity. In the quarter ended June 27, 2020, we recorded $11 million of bad debt charges primarily related to the effects of the COVID-19 pandemic.

In the quarter ended June 27, 2020, we recorded $20 million of charges to reserve for increased excess and obsolete inventory related primarily to canceled orders of seasonal inventory and $20 million of charges for the impairment of intangible assets primarily as a result of the COVID-19 pandemic. We could be required to record increased excess and obsolete inventory reserves due to continued decreased net sales or additional noncash impairment charges related to our intangible assets or goodwill due to reductions in cash flows that are more than short-term in nature. Additionally, the operations of our retail stores and our manufacturing facilities may not generate sales sufficient to offset fixed operating expenses, which could adversely affect our income and could adversely affect the value of our owned and leased properties, potentially requiring us to recognize significant noncash impairment charges.

We have been taking steps to mitigate the potential risks to us posed by the spread and related circumstances and impacts of COVID-19. We are focused on addressing these recent challenges by preserving our liquidity and managing our cash flow with preemptive actions designed to enhance our ability to meet our short-term liquidity needs. Such actions include, but are not limited to, focusing on channels that continue to generate sales, including mass retail and online; selling personal protective equipment (“PPE”) such as cloth face coverings and gowns; operating our manufacturing and distribution facilities on a demand-adjusted basis; reducing our discretionary spending such as certain media and marketing expenses; focused working capital management; reducing capital expenditures; suspending our share repurchase program until further notice; reducing payroll costs, through temporary employee furloughs and pay cuts; working globally to maximize our participation in all eligible government or other initiatives available to businesses or employees impacted by the COVID-19 pandemic; engaging with landlords to negotiate rent deferrals or other rent concessions; issuing new debt and amending certain existing debt facilities. These efforts may not be enough to offset anticipated declines in net sales and earnings and we may not be able to access sufficient additional working capital to meet our liquidity needs.

Outlook for 2020

We issued first-quarter and full-year 2020 guidance on February 7, 2020, which excluded any impact from the spread of the COVID-19 pandemic. Due to the uncertainty and rapidly changing environment relating to the pandemic, on March 25, 2020, we withdrew the guidance for the first quarter and full year. We will not provide a quarterly and full-year updated outlook until visibility of the pandemic’s effect on global economies improves. However, we have provided that we expect more than $150 million of PPE sales, to generate positive cash flow from operating activities and a tax rate of approximately 17.5% in the second half of 2020.

Table of Contents

Seasonality and Other Factors

Absent the effects of the COVID-19 pandemic, our operating results are typically subject to some variability due to seasonality and other factors. For instance, we have historically generated higher sales during the back-to-school and holiday shopping seasons and during periods of cooler weather, which benefits certain product categories such as fleece. Sales levels in any period are also impacted by customer decisions to increase or decrease their inventory levels in response to anticipated consumer demand. Our customers may cancel orders, change delivery schedules or change the mix of products ordered with minimal notice to us. Media, advertising and promotion expenses may vary from period to period during a fiscal year depending on the timing of our advertising campaigns for retail selling seasons and product introductions. We expect the duration and scope of the COVID-19 pandemic to alter these patterns at least through the remainder of 2020.

Although the majority of our products are replenishment in nature and tend to be purchased by consumers on a planned, rather than on an impulse, basis, our sales are impacted by discretionary consumer spending trends. Discretionary spending is affected by many factors that are outside our control, including, among others, general business conditions, interest rates, inflation, consumer debt levels, the availability of consumer credit, currency exchange rates, taxation, energy prices, unemployment trends and other matters that influence consumer confidence and spending. Consumers’ purchases of discretionary items, including our products, could decline during periods when disposable income is lower, when prices increase in response to rising costs, or in periods of actual or perceived unfavorable economic conditions. In addition, the COVID-19 pandemic may continue to result in decreased consumer confidence and lower consumer spending. As a result, consumers may choose to purchase fewer of our products, to purchase lower-priced products of our competitors in response to higher prices for our products, or may choose not to purchase our products at prices that reflect our price increases that become effective from time to time.

Changes in product sales mix can impact our gross profit as the percentage of our sales attributable to higher margin products, such as intimate apparel and men’s underwear, and lower margin products, such as seasonal and replenishable activewear, fluctuate from time to time. In addition, sales attributable to higher and lower margin products within the same product category fluctuate from time to time. Our customers may change the mix of products ordered with minimal notice to us, which makes trends in product sales mix difficult to predict. However, certain changes in product sales mix are seasonal in nature, as sales of socks, hosiery and fleece products generally have higher sales during the last two quarters (July to December) of each fiscal year as a result of cooler weather, back-to-school shopping and holidays, while other changes in product mix may be attributable to consumers’ preferences and discretionary spending.

Overview of the Second Quarter Ended June 27, 2020

The COVID-19 pandemic adversely impacted our business operations and results of operations for the second quarter of 2020. As the COVID-19 virus continued to spread around the world in the second quarter of 2020, net sales and profits across our apparel businesses decreased dramatically. During the second quarter of 2020, we sold PPE globally to governments, large organizations, business-to-business customers and consumers including more than 450 million cloth face coverings and more than 20 million medical gowns for use during the COVID-19 pandemic to the U.S. government.

Key financial results are as follows:


•	Total net sales in the second quarter of 2020 were $1.7 billion, compared with $1.8 billion in the same period of 2019, representing a 1% decrease.

•

Operating profit increased 5% to $242 million in the second quarter of 2020, compared with $230 million in the same period of 2019. As a percentage of sales, operating profit was 13.9% in the second quarter of 2020 compared to 13.0% in the same period of 2019. Included within operating profit were restructuring and other action-related charges of $63 million and $13 million for the quarters ended June 27, 2020 and June 29, 2019, respectively.


•	Sales of PPE used to help mitigate the spread of the COVID-19 virus were $752 million in the second quarter of 2020.


•	In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 pandemic and the associated impact on future earnings, we amended our Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis.


•	In May 2020, we issued $700 million aggregate principal amount of 5.375% Senior Notes which mature in May 2025. The net proceeds from the issuance of $691 million were used to repay all outstanding borrowings under our Revolving Loan Facility, pay related fees and expenses, and for general corporate purposes.

Table of Contents

Condensed Consolidated Results of Operations — Second Quarter Ended June 27, 2020 Compared with Second Quarter Ended June 29, 2019



	Quarters Ended
	June 27, 2020		June 29, 2019		Higher (Lower)			Percent Change
	(dollars in thousands)
Net sales	$	1,738,779	$	1,760,927	$	(22,148	)	(1.3	)%
Cost of sales	1,105,767		1,085,404		20,363			1.9
Gross profit	633,012		675,523		(42,511		)	(6.3	)
Selling, general and administrative expenses	391,476		445,923		(54,447		)	(12.2	)
Operating profit	241,536		229,600		11,936			5.2
Other expenses	5,050		8,249		(3,199		)	(38.8	)
Interest expense, net	41,659		46,522		(4,863		)	(10.5	)
Income before income tax expense	194,827		174,829		19,998			11.4
Income tax expense	33,646		25,274		8,372			33.1
Net income	$	161,181	$	149,555	$	11,626		7.8	%

Net Sales

Shipments slowed through most of the second quarter as we and many of our retail customers temporarily closed stores and customer orders were canceled in response to the global expansion of COVID-19, and net sales and profit trends across our apparel businesses decreased dramatically. Our e-commerce sites have remained open in all regions. Most of our retail stores were reopened by the end of the second quarter but have and are expected to continue to experience significant reductions in traffic and therefore, revenue. During the second quarter of 2020, we sold PPE globally to governments, large organizations, business-to-business customers and consumers including more than 450 million cloth face coverings and more than 20 million medical gowns for use during the COVID-19 pandemic to the U.S. government.

Net sales decreased 1% during the second quarter of 2020 primarily due to the following:


•	The disruption of our U.S. and International apparel businesses related to the negative effects of the COVID-19 pandemic;


•	The exit of our C9 Champion program at Target and the DKNY Intimates license in 2019 which, together, represented approximately $119 million of net sales in the second quarter of 2019; and


•	The unfavorable impact from foreign exchange rates in our International business of approximately $14 million.

Partially offset by:


•	Net sales of PPE of $752 million in the second quarter of 2020.

Operating Profit

Operating profit as a percentage of net sales was 13.9%, representing an increase from 13.0% in the prior year. Increased operating profit was the result of lower selling, general and administrative expenses driven by temporary cost savings initiatives implemented in response to the COVID-19 pandemic. Included in operating profit in the second quarter of 2020 and 2019 were restructuring and other action-related charges of $63 million and $13 million, respectively, including asset write-down charges recorded as a result of the on-going effects of the COVID-19 pandemic in 2020.

Other Highlights

Other Expenses – Other expenses decreased $3 million in the second quarter of 2020 compared to the second quarter of 2019 due to lower pension expense and lower funding fees for sales of accounts receivable to financial institutions in 2020.

Interest Expense – Interest expense was lower by $5 million in the second quarter of 2020 compared to the second quarter of 2019 driven by the impact of the cross-currency swap contracts entered into in July 2019 and a lower weighted average interest rate on our borrowings, partially offset by higher outstanding debt balances during the quarter. Our weighted average interest rate on our outstanding debt was 3.32% for the second quarter of 2020, compared to 4.13% for the second quarter of 2019.

Income Tax Expense – Our effective income tax rate was 17.3% and 14.5% for the second quarters of 2020 and 2019, respectively. The higher effective tax rate for the quarter ended June 27, 2020 was primarily due to the change in jurisdictional mix of income attributable to the economic impacts of COVID-19.

Table of Contents

Operating Results by Business Segment — Second Quarter Ended June 27, 2020 Compared with Second Quarter Ended June 29, 2019



	Net Sales
	Quarters Ended
	June 27, 2020		June 29, 2019		Higher (Lower)			Percent Change
	(dollars in thousands)
Innerwear	$	1,094,814	$	678,604	$	416,210		61.3	%
Activewear	168,379		448,277		(279,898		)	(62.4	)
International	456,875		568,863		(111,988		)	(19.7	)
Other	18,711		65,183		(46,472		)	(71.3	)
Total	$	1,738,779	$	1,760,927	$	(22,148	)	(1.3	)%



	Operating Profit and Margin
	Quarters Ended
	June 27, 2020					June 29, 2019					Higher (Lower)			Percent Change
	(dollars in thousands)
Innerwear	$	304,524		27.8	%	$	149,530		22.0	%	$	154,994		103.7	%
Activewear	(5,751		)	(3.4	)	68,779			15.3		(74,530		)	(108.4	)
International	79,124			17.3		81,078			14.3		(1,954		)	(2.4	)
Other	(12,270		)	(65.6	)	6,032			9.3		(18,302		)	(303.4	)
Corporate	(124,091		)	NM		(75,819		)	NM		(48,272		)	(63.7	)
Total	$	241,536		13.9	%	$	229,600		13.0	%	$	11,936		5.2	%

Innerwear

Innerwear net sales increased 61% compared to the second quarter of 2019 driven by $614 million of net sales of PPE. This increase was partially offset by a 55% and 21% decline in net sales in our intimate apparel and basics businesses, respectively, primarily as a result of the negative impact of the COVID-19 pandemic. In addition, the exit of the C9 Champion program at Target and the DKNY Intimates license in 2019 represented an approximately $21 million decrease in net sales in the second quarter of 2020 compared to the second quarter of 2019.

Innerwear operating margin was 27.8%, an increase from 22.0% in the same period a year ago. Operating margin enhancement resulted primarily from fixed cost leverage from higher sales and temporary cost reduction initiatives.

Activewear

Activewear net sales decreased 62% compared to the second quarter last year primarily as a result of the negative impact of the COVID-19 pandemic. In addition, the exit of the C9 Champion program at Target in 2019 represented approximately $98 million of the net sales decrease in the second quarter of 2020 compared to the second quarter of 2019.

Activewear operating margin decreased as a result of lower sales, including the exit of the C9 Champion program at Target, minimum royalty payments in our sports license business and higher selling, general and administrative expenses as a percentage of net sales. Lower variable costs as a result of decreased net sales and temporary cost savings initiatives implemented in response to the COVID-19 pandemic reduced selling, general and administrative costs, but not at the same rate as the decline in sales.

International

Net sales in the International segment decreased 20% as a result of the negative impact of the COVID-19 pandemic and the unfavorable impact of foreign currency exchange rates of approximately $14 million. International net sales on a constant currency basis, defined as net sales excluding the impact of foreign currency, decreased 17%. The impact of foreign exchange rates is calculated by applying prior period exchange rates to the current year financial results. Sales of PPE increased International segment net sales by $139 million in the second quarter of 2020.

International operating margin was 17.3%, an increase from 14.3% in the same period a year ago, resulting from various temporary cost savings initiatives.

Table of Contents

Other

Other net sales decreased as a result of decreased traffic at our retail outlets due to temporary store closures during the second quarter of 2020 as a result of the COVID-19 pandemic and continued declines in hosiery sales in the United States. Operating margin decreased due to the decrease in sales volume at our retail outlets.

Corporate

Corporate expenses included certain administrative costs including restructuring and other action-related charges. Corporate expenses were higher in the second quarter of 2020 compared to the second quarter of 2019 due to higher restructuring and other action-related charges. Included in restructuring and other action-related charges in the second quarter of 2020 were $52 million of asset write-down charges recorded as a result of the on-going effects of the COVID-19 pandemic. Supply chain actions include actions to reduce overhead costs. Program exit charges are costs associated with exiting the C9 Champion business with Target and the DKNY Intimates license. Other restructuring costs include action-related costs such as workforce reductions, as well as acquisition and integration charges for smaller acquisitions in 2019.



	Quarters Ended
	June 27, 2020		June 29, 2019
	(dollars in thousands)
Restructuring and other action-related charges included in operating profit:
Supply chain actions - 2019	$	1,896	$	12,598
Supply chain actions - 2020	3,241		—
Program exit costs	1,285		—
Other restructuring costs	4,695		11
COVID-19 related charges:
Bad debt	11,375		—
Inventory	20,485		—
Intangible assets	20,319		—
Total restructuring and other action-related charges included in operating profit	$	63,296	$	12,609

Condensed Consolidated Results of Operations — Six Months Ended June 27, 2020 Compared with Six Months Ended June 29, 2019



	Six Months Ended
	June 27, 2020		June 29, 2019		Higher (Lower)			Percent Change
	(dollars in thousands)
Net sales	$	3,055,241	$	3,348,951	$	(293,710	)	(8.8	)%
Cost of sales	1,948,497		2,053,397		(104,900		)	(5.1	)
Gross profit	1,106,744		1,295,554		(188,810		)	(14.6	)
Selling, general and administrative expenses	831,078		916,310		(85,232		)	(9.3	)
Operating profit	275,666		379,244		(103,578		)	(27.3	)
Other expenses	11,540		15,700		(4,160		)	(26.5	)
Interest expense, net	78,508		94,581		(16,073		)	(17.0	)
Income before income tax expense	185,618		268,963		(83,345		)	(31.0	)
Income tax expense	32,311		38,320		(6,009		)	(15.7	)
Net income	$	153,307	$	230,643	$	(77,336	)	(33.5	)%

Net Sales

Net sales decreased 9% during the six months of 2020 primarily due to the following:


•	The disruption of our U.S. and International apparel businesses related to the negative effects of the COVID-19 pandemic, including temporary closures of retail stores owned and operated by us, as well as canceled orders from our wholesale brick- and-mortar customers;


•	The exit of our C9 Champion program at Target and the DKNY Intimates license in 2019 which, together, represented approximately $213 million of net sales in the six months of 2019; and


•	The unfavorable impact from foreign exchange rates in our International business of approximately $34 million.

Partially offset by:

Table of Contents


•	Net sales of PPE of $752 million in the six months of 2020.

Operating Profit

Operating profit as a percentage of net sales was 9.0%, representing a decrease from 11.3% in the prior year. Decreased operating profit was the result of lower sales volume in our apparel businesses including the exit of our C9 Champion program at Target in 2019, higher manufacturing variances as a result of decreases in manufacturing facility production levels in our global supply chain due to the business disruption caused by the COVID-19 pandemic and higher bad debt expense. These decreases were partially offset by temporary cost savings initiatives implemented in response to the COVID-19 pandemic. Included in operating profit in the six months of 2020 and 2019 were restructuring and other action-related charges of $92 million and $34 million, respectively, including asset write-down charges recorded as a result of the on-going effects of the COVID-19 pandemic in 2020.

Other Highlights

Other Expenses – Other expenses decreased $4 million in the six months of 2020 compared to the same period in 2019 due to lower pension expense and lower funding fees for sales of accounts receivable to financial institutions in 2020.

Interest Expense – Interest expense was lower by $16 million in the six months of 2020 compared to the same period in 2019, primarily driven by the impact of the cross-currency swap contracts entered into in July 2019 and a lower weighted average interest rate on our borrowings. Our weighted average interest rate on our outstanding debt was 3.55% for the six months of 2020, compared to 4.15% for the six months of 2019.

Income Tax Expense – Our effective income tax rate was 17.4% and 14.2% for the six months of 2020 and 2019, respectively. The higher effective tax rate for the six months ended June 27, 2020 was primarily due to the change in jurisdictional mix of income attributable to the economic impacts of COVID-19. During the six months ended June 27, 2020, the Internal Revenue Service closed the examination of the income tax years ended January 2, 2016 and December 31, 2016. The examination resulted in an immaterial adjustment which had been accrued as an uncertain tax benefit in a prior period.

Operating Results by Business Segment — Six Months Ended June 27, 2020 Compared with Six Months Ended June 29, 2019



	Net Sales
	Six Months Ended
	June 27, 2020		June 29, 2019		Higher (Lower)			Percent Change
	(dollars in thousands)
Innerwear	$	1,517,216	$	1,154,549	$	362,667		31.4	%
Activewear	456,379		853,617		(397,238		)	(46.5	)
International	1,012,776		1,215,043		(202,267		)	(16.6	)
Other	68,870		125,742		(56,872		)	(45.2	)
Total	$	3,055,241	$	3,348,951	$	(293,710	)	(8.8	)%



	Operating Profit and Margin
	Six Months Ended
	June 27, 2020					June 29, 2019					Higher (Lower)			Percent Change
	(dollars in thousands)
Innerwear	$	386,075		25.4	%	$	254,156		22.0	%	$	131,919		51.9	%
Activewear	2,357			0.5		112,372			13.2		(110,015		)	(97.9	)
International	131,142			12.9		180,851			14.9		(49,709		)	(27.5	)
Other	(18,395		)	(26.7	)	6,786			5.4		(25,181		)	(371.1	)
Corporate	(225,513		)	NM		(174,921		)	NM		(50,592		)	(28.9	)
Total	$	275,666		9.0	%	$	379,244		11.3	%	$	(103,578	)	(27.3	)%

Table of Contents

Innerwear

Innerwear net sales increased 31% compared to the six months of 2019 driven by $614 million of net sales of PPE. This increase was partially offset by a 37% and 16% decline in net sales in our intimate apparel and basics businesses, respectively, primarily as a result of the negative impact of the COVID-19 pandemic. The continued rapid expansion of COVID-19 in the six months of 2020 resulted in a sharp decline in apparel net sales and obscured the turnaround underway in our Innerwear segment as our basics business innovations and intimate apparel business revitalization plans began to regain pre-COVID-19 momentum across channels late in the six months. In addition, net sales in our Innerwear segment decreased as a result of the exit of the C9 Champion program at Target and the DKNY Intimates license in 2019.

Innerwear operating margin was 25.4%, an increase from 22.0% in the same period a year ago. Operating margin enhancement resulted primarily from fixed cost leverage from higher sales and temporary cost reduction initiatives.

Activewear

Activewear net sales decreased 47% compared to the six months last year primarily as a result of the negative impact of the COVID-19 pandemic. In addition, the exit of the C9 Champion program at Target in 2019 represented approximately $182 million of the net sales decrease in the six months of 2020 compared to the six months of 2019.

Activewear operating margin was 0.5%, representing a decrease from 13.2% in the same period a year ago. The decrease was a result of lower sales, including the exit of the C9 Champion program at Target, minimum royalty payments in our sports license business, higher manufacturing variances as a result of decreases in manufacturing facility production levels in our global supply chain due to the business disruption caused by the COVID-19 pandemic and higher selling, general and administrative expenses as a percentage of net sales. Lower variable costs as a result of decreased net sales and temporary cost savings initiatives implemented in response to the COVID-19 pandemic reduced selling, general and administrative costs, but not at the same rate as the decline in sales.

International

Net sales in the International segment decreased 17% as a result of the negative impact of the COVID-19 pandemic and the unfavorable impact of foreign currency exchange rates of approximately $34 million. International net sales on a constant currency basis, defined as net sales excluding the impact of foreign currency, decreased 14%. The impact of foreign exchange rates is calculated by applying prior period exchange rates to the current year financial results. Sales of PPE increased International segment net sales by $139 million in the six months of 2020.

International operating margin was 12.9%, a decrease from 14.9% in the same period a year ago, primarily due to decreased sales partially offset by various temporary cost reduction initiatives.

Other

Other net sales decreased as a result decreased traffic at our retail outlets due to temporary store closures during the six months of 2020 as a result of the COVID-19 pandemic and continued declines in hosiery sales in the United States. Operating margin decreased due to the decrease in sales volume at our retail outlets.

Table of Contents

Corporate

Corporate expenses included certain administrative costs including restructuring and other action-related charges. Corporate expenses were higher in the six months of 2020 compared to the same period of 2019 due to higher restructuring and other action-related charges and higher bad debt expense as a result of charges for bankruptcies partially offset by lower compensation costs and other cost savings initiatives implemented in response to the COVID-19 pandemic. Included in restructuring and other action-related charges in the six months ended June 27, 2020 were $52 million of asset write-down charges recorded as a result of the on-going effects of the COVID-19 pandemic. Supply chain actions include actions to reduce overhead costs. Program exit charges are costs associated with exiting the C9 Champion business with Target and the DKNY Intimates license. Other restructuring costs include action-related costs such as workforce reductions, as well as acquisition and integration charges for smaller acquisitions in 2019.



	Six Months Ended
	June 27, 2020		June 29, 2019
	(dollars in thousands)
Restructuring and other action-related charges included in operating profit:
Supply chain actions - 2019	$	5,698	$	30,290
Supply chain actions - 2020	13,504		—
Program exit costs	9,500		—
Other restructuring costs	11,614		3,692
COVID-19 related charges:
Bad debt	11,375		—
Inventory	20,485		—
Intangible assets	20,319		—
Total restructuring and other action-related charges included in operating profit	$	92,495	$	33,982

Liquidity and Capital Resources

Cash Requirements and Trends and Uncertainties Affecting Liquidity

We rely on our cash flows generated from operations and the borrowing capacity under our credit facilities to meet the cash requirements of our business. The primary cash requirements of our business are payments to our employees and vendors in the normal course of business, capital expenditures, maturities of debt and related interest payments, business acquisitions, contributions to our pension plans, repurchases of our stock, regular quarterly dividend payments and income tax payments. The rapid expansion of the COVID-19 pandemic has resulted in a decline in net sales and earnings in the six months of 2020, which has a corresponding impact on our liquidity. We are focused on preserving our liquidity and managing our cash flow during these unprecedented conditions with preemptive actions to enhance our ability to meet our short-term liquidity needs. Such actions include, but are not limited to, selling PPE; operating manufacturing and distribution facilities on a demand-adjusted basis; reducing discretionary spending such as certain media and marketing expenses; focused working capital management; reducing capital expenditures; suspending our share repurchase program until further notice; reducing payroll costs, through temporary employee furloughs and pay cuts; working globally to maximize our participation in all eligible government or other initiatives available to businesses or employees impacted by the COVID-19 pandemic; engaging with landlords to negotiate rent deferrals or other rent concessions; issuing new debt and amending certain existing debt facilities.

In May 2020, we issued $700 million aggregate principal amount of 5.375% Senior Notes which will mature on May 15, 2025. The net proceeds from the issuance of $691 million were used to repay all outstanding borrowings under our Revolving Loan Facility, pay related fees and expenses, and for general corporate purposes.

Table of Contents

In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 pandemic and the associated impact on future earnings, we amended our Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. The amendment effects changes to certain provisions and covenants under the Senior Secured Credit Facility during the period beginning with the fiscal quarter ending June 27, 2020 and continuing through the fiscal quarter ending July 3, 2021 (such period of time, the “Covenant Relief Period”), including: (a) suspension of compliance with the maximum leverage ratio; (b) reduction of the minimum interest coverage ratio from 3.00 to 1.00 to (i) 2.00 to 1.00 for the fiscal quarters ending June 27, 2020 through April 3, 2021 and (ii) 2.25 to 1.00 for the fiscal quarter ending July 3, 2021; (c) a minimum last twelve months EBITDA covenant of $625 million as of June 27, 2020, $505 million as of September 26, 2020, $445 million as of January 2, 2021, $435 million as of April 3, 2021 and $505 million as of July 3, 2021; (d) a minimum liquidity covenant of $300 million, increasing to $400 million upon certain conditions; (e) increased limitations on investments, acquisitions, restricted payments and the incurrence of indebtedness; and (f) anti-cash hoarding provisions. During the Covenant Relief Period, the applicable margin and applicable commitment fee margin will be calculated assuming the leverage ratio is greater than or equal to 4.50 to 1.00. The amendment also permanently amends the definition of “leverage ratio” for purposes of the financial covenant calculation to remove the maximum amount of cash allowed to be netted from the definition of “indebtedness” and to allow for the netting of cash from certain foreign subsidiaries. After obtaining the debt amendment, we expect to maintain compliance with our covenants for at least one year from the issuance of these financial statements based on our current expectations and forecasts. If economic conditions caused by the COVID-19 pandemic worsen and our earnings and operating cash flows do not start to recover as currently estimated by us, this could impact our ability to maintain compliance with our amended financial covenants and require us to seek additional amendments to our Senior Secured Credit Facility. If we are not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, our lenders could require us to repay our outstanding debt. In that situation, we may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders.

We cannot assure you that our assumptions used to estimate our liquidity requirements will remain accurate due to the unprecedented nature of the disruption to our operations and the unpredictability of the COVID-19 pandemic. As a consequence, our estimates of the duration of the pandemic and the severity of the impact on our future earnings and cash flows could change and have a material impact on our results of operations and financial condition. We believe we have sufficient cash and available borrowings for our foreseeable liquidity needs.

Our primary sources of liquidity are cash generated from global operations and cash available under our Revolving Loan Facility, our Accounts Receivable Securitization Facility and our international loan facilities, including our Australian Revolving Loan Facility and our European Revolving Loan Facility.

We had the following borrowing capacity and available liquidity under our credit facilities as of June 27, 2020:



	As of June 27, 2020
	Borrowing Capacity		Available Liquidity
	(dollars in thousands)
Senior Secured Credit Facility:
Revolving Loan Facility	$	1,000,000	$	957,718
Australian Revolving Loan Facility	41,214		6,869
European Revolving Loan Facility	112,512		—
Accounts Receivable Securitization Facility⁽¹⁾	81,868		81,868
Other international credit facilities	128,166		112,458
Total liquidity from credit facilities	$	1,363,760	$	1,158,913
Cash and cash equivalents			683,114
Total liquidity			$	1,842,027


(1)	Borrowing availability under the Accounts Receivable Securitization Facility is subject to a quarterly fluctuating facility limit, not to exceed $225 million, and permitted only to the extent that the face of the receivables in the collateral pool, net of applicable reserves and other deductions, exceeds the outstanding loans.

The following have impacted or may impact our liquidity:


•	The negative impact of the COVID-19 pandemic on our business as discussed above under “Impact of COVID-19 on Our Business.”


•	For the six months ended June 27, 2020 and prior to the expansion of COVID-19, we entered into transactions to repurchase approximately 14.5 million shares of our common stock at a total cost of $200 million. At June 27, 2020, the remaining repurchase authorization under our current share repurchase program totaled approximately 25.5

Table of Contents

million shares. While we may repurchase additional shares of our common stock in the future, the program has been suspended in connection with the amendment to our Senior Secured Credit Facility described above.


•	We have historically paid a regular quarterly dividend. The declaration of any future dividends and, if declared, the amount of any such dividends, will be subject to our actual future earnings, capital requirements, regulatory restrictions, debt covenants, other contractual restrictions and to the discretion of our Board of Directors.


•	We have principal and interest obligations under our debt and ongoing financial covenants under those debt facilities, even after taking into account recent amendments.


•	We have invested in efforts to accelerate worldwide omnichannel and global growth initiatives, as well as marketing and brand building. We anticipate capital expenditures to decrease for the remainder of 2020 compared to the prior year as we tightly manage spending to help mitigate the potential negative impact of the COVID-19 pandemic on our business and liquidity.


•	We expect to continue to invest in efforts to improve operating efficiencies and lower costs.


•	Although currently prohibited under our Senior Secured Credit Facility, in the future, we may pursue strategic business acquisitions.


•	We made a contribution of $25 million to our U.S. pension plan in the six months ended June 27, 2020. We may also elect to make additional voluntary contributions.


•	We may increase or decrease the portion of the current-year income of our foreign subsidiaries that we remit to the United States, which could impact our effective income tax rate. Consistent with our investment strategy as it pertains to our historical foreign earnings as of December 28, 2019, we intend to remit historical foreign earnings totaling approximately $1.0 billion.

•

We are obligated to make installment payments over an eight-year period related to our transition tax liability resulting from the implementation of the Tax Act, which began in 2018, in addition to any estimated income taxes due based on current year taxable income. In the six months ended June 27, 2020, we made no installment payments on our transition tax liability as the CARES Act extended the payment due date to July 15, 2020. On July 15, 2020, we made an installment payment of $10 million on our transition tax liability. We currently have a remaining balance due of approximately $91 million to be paid in installment payments through 2025.


•	In May 2020, we issued $700 million aggregate principal amount of 5.375% Senior Notes. The net proceeds from the issuance were used to repay all outstanding borrowings under our Revolving Loan Facility, pay related fees and expenses, and for general corporate purposes.


•	We have made more than 450 million face masks and more than 20 million medical gowns for the U.S. government. We are also producing masks to supply to consumers and large employers seeking to reopen business operations after being closed as a result of the COVID-19 pandemic. We expect to sell more than $150 million of PPE in the last half of 2020.


•	We expect the employee furloughs and pay cuts, as well as reductions in discretionary spending such as media and marketing expenses, to save approximately $200 million in 2020.

Sources and Uses of Our Cash

The information presented below regarding the sources and uses of our cash flows for the six months ended June 27, 2020 and June 29, 2019 was derived from our condensed consolidated financial statements.



	Six Months Ended
	June 27, 2020			June 29, 2019
	(dollars in thousands)
Operating activities	$	(17,793	)	$	(57,363	)
Investing activities	(40,623		)	(57,767		)
Financing activities	415,318			(64,221		)
Effect of changes in foreign currency exchange rates on cash	(2,669		)	4,282
Change in cash, cash equivalents and restricted cash	354,233			(175,069		)
Cash, cash equivalents and restricted cash at beginning of year	329,923			455,732
Cash, cash equivalents and restricted cash at end of period	684,156			280,663
Less restricted cash at end of period	1,042			22,722
Cash and cash equivalents per balance sheet at end of period	$	683,114		$	257,941

Table of Contents

Operating Activities

Our overall liquidity has historically been driven by our cash flow provided by operating activities, which is dependent on net income and changes in our working capital, and is subject to certain risks related to the COVID-19 pandemic. We typically use cash during the first half of the year and generate most of our cash flow in the second half of the year. As compared to the prior year, the lower net cash used by operating activities was primarily due to improved working capital management. Cash used by operating activities includes a $25 million and a $26 million pension contribution made in the first quarter of 2020 and 2019, respectively.

Investing Activities

Investing activities in the six months of 2020 and 2019 primarily include capital investments into our business to support our global growth initiatives. We anticipate capital expenditures to decrease for the remainder of the year compared to the prior year as we tightly manage spending to help mitigate the potential negative impact of the COVID-19 pandemic on our business and liquidity.

Financing Activities

Net cash from financing activities increased primarily as a result of higher borrowings as compared to the same period of 2019 resulting from the issuance of $700 million aggregate principal amount of 5.375% Senior Notes in May 2020. We increased our borrowings in the six months of 2020 primarily to strengthen our cash position and to provide us with additional financial flexibility to manage our business with a safety-first emphasis during the unknown duration and impact of the COVID-19 pandemic.

Financing Arrangements

In March 2020, we amended the Accounts Receivable Securitization Facility. This amendment primarily decreased the fluctuating facility limit to $225 million (previously $300 million) and extended the maturity date to March 2021. As a result of the COVID-19 pandemic, in May 2020, we amended the Accounts Receivable Securitization Facility which changed certain ratios, inserted a floor and raised pricing, as well as removed certain receivables from being pledged as collateral for the facility, increased limits on other receivables pledged as collateral and required us to maintain the same minimum liquidity covenant contained in the Senior Secured Credit Facility.

In May 2020, we issued $700 million aggregate principal amount of 5.375% Senior Notes. The net proceeds of $691 million from the issuance were used to repay all outstanding borrowings under our Revolving Loan Facility, pay related fees and expenses, and for general corporate purposes.

We believe our financing structure provides a secure base to support our operations and key business strategies. As of June 27, 2020, we were in compliance with all financial covenants under our credit facilities and other outstanding indebtedness. We continue to monitor our covenant compliance carefully. Under the terms of our Senior Secured Credit Facility, we are required to maintain a minimum interest coverage ratio and a maximum leverage ratio. The interest coverage ratio covenant is the ratio of our EBITDA for the preceding four fiscal quarters to our consolidated total interest expense and the leverage ratio covenant is the ratio of our net debt to EBITDA for the preceding four fiscal quarters. EBITDA is defined as earnings before interest, income taxes, depreciation expense and amortization, as computed pursuant to the Senior Secured Credit Facility. In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 pandemic and the associated impact on future earnings, we amended our Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. After obtaining the debt amendment discussed above, we expect to maintain compliance with our covenants during the Covenant Relief Period, however economic conditions or the occurrence of events discussed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 28, 2019 and our Quarterly Report on Form 10-Q for the quarter ended March 28, 2020 or other SEC filings could cause noncompliance.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements within the meaning of Item 303(a)(4) of SEC Regulation S-K.

Critical Accounting Policies and Estimates

We have chosen accounting policies that we believe are appropriate to accurately and fairly report our operating results and financial condition in conformity with accounting principles generally accepted in the United States. We apply these accounting policies in a consistent manner. Our significant accounting policies are discussed in Note, “Summary of Significant Accounting Policies,” to our financial statements included in our Annual Report on Form 10-K for the year ended December 28, 2019.

Table of Contents

The application of critical accounting policies requires that we make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. These estimates and assumptions are based on historical and other factors believed to be reasonable under the circumstances. We evaluate these estimates and assumptions on an ongoing basis and may retain outside consultants to assist in our evaluation. If actual results ultimately differ from previous estimates, the revisions are included in results of operations in the period in which the actual amounts become known. The critical accounting policies that involve the most significant management judgments and estimates used in preparation of our financial statements, or are the most sensitive to change from outside factors, are discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 28, 2019. There have been no material changes in these policies from those described in our Annual Report on Form 10-K for the year ended December 28, 2019.

Recently Issued Accounting Pronouncements

For a summary of recently issued accounting pronouncements, see Note, “Recent Accounting Pronouncements” to our financial statements included in this Quarterly Report on Form 10-Q.



Item 3.	Quantitative and Qualitative Disclosures about Market Risk

There have been no significant changes in our market risk exposures from those described in Item 7A of our Annual Report on Form 10-K for the year ended December 28, 2019.



Item 4.	Controls and Procedures

Disclosure Controls and Procedures

As required by Exchange Act Rule 13a-15(b), our management, including our Chief Executive Officer and Interim Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 27, 2020 due to a material weakness in internal control over financial reporting described in management’s annual report on internal control over financial reporting in our Annual Report on Form 10-K for the year ended December 28, 2019.

Notwithstanding the identified material weakness, management, including our principal executive officer and principal financial officer, have determined, based on the procedures we have performed, that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly represent in all material respects our financial condition, results of operations and cash flows at June 27, 2020 and for the periods presented in accordance with U.S. GAAP.

Remediation Plan for Material Weakness

Management continues to enhance its internal control over financial reporting and to take steps to remediate the material weakness identified during the year ended December 28, 2019 related to income taxes. During the quarter ended June 27, 2020, we made progress in our remediation of the control deficiency noted above. In order to remediate the material weakness in our internal controls related to accounting for income taxes, management enhanced processes and internal controls related to deferred income taxes, effective income tax rate reconciliation and related disclosures. These enhanced controls include documentation evidencing the effective design and operation of annual and quarterly internal controls related to various aspects of deferred taxes and tax rate reconciliation. Based on the testing performed through June 27, 2020, we believe that our redesigned and enhanced processes will operate effectively.

We believe the measures described above will remediate the control deficiencies we have identified and strengthen our internal control over financial reporting. We are committed to continuing to improve our internal control processes and will continue to review, optimize and enhance our financial reporting controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, we may take additional measures to address control deficiencies, or we may modify certain of the remediation measures described above. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

Table of Contents

Changes in Internal Control over Financial Reporting

In connection with the evaluation required by Exchange Act Rule 13a-15(d), our management, including our Chief Executive Officer and Interim Chief Financial Officer, concluded that, aside from the enhancements and process improvements made in connection with our remediation plan described above, no other changes in our internal control over financial reporting occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II



Item 1.	Legal Proceedings

Although we are subject to various claims and legal actions that occur from time to time in the ordinary course of our business, we are not party to any pending legal proceedings that we believe could have a material adverse effect on our business, results of operations, financial condition or cash flows.

Table of Contents



Item 1A.	Risk Factors

The risk factors that affect our business and financial results that are discussed in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 28, 2019 and in Part II, Item 1A, of our Quarterly Report on Form 10-Q for the quarter ended March 28, 2020. These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by the forward-looking statements contained in this report. There are no material changes to the risk factors previously disclosed, nor have we identified any previously undisclosed risks that could materially adversely affect our business and financial results.

Table of Contents



Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds

None.



Item 3.	Defaults Upon Senior Securities

None.



Item 4.	Mine Safety Disclosures

Not applicable.



Item 5.	Other Information

None.

Table of Contents



Item 6.	Exhibits



Exhibit Number		Description

3.1		Articles of Amendment and Restatement of Hanesbrands Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2006).

3.2		Articles Supplementary (Junior Participating Preferred Stock, Series A) (incorporated by reference from Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2006).

3.3		Articles of Amendment to Articles of Amendment and Restatement of Hanesbrands Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 28, 2015).

3.4		Articles Supplementary (Reclassifying Junior Participating Preferred Stock, Series A) (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 2, 2015).

3.5		Amended and Restated Bylaws of Hanesbrands Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 26, 2017).

4.1		Indenture, dated May 4, 2020, among Hanesbrands Inc., the guarantors named therein, and U.S. Bank National Association, as trustee (incorporated by reference from Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 4, 2020).

4.2		Form of 5.375% Senior Notes due 2025 (incorporated by reference from Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 4, 2020).
10.1		Hanesbrands Inc. 2020 Omnibus Incentive Plan (incorporated by reference from Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 29, 2020).*

10.2		First Amendment and Waiver dated April 27, 2020 to Fourth Amended and Restated Credit Agreement among Hanesbrands Inc., MFB International Holdings S.à r.l., HBI Australia Acquisition Co. Pty Ltd, the lenders party thereto from time to time and JPMorgan Chase Bank N.A., as the administrative agent and the collateral agent (incorporated by reference from Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 30, 2020).

10.3		Transition and Retirement Agreement dated as of May 4, 2020 by and between Hanesbrands Inc. and Gerald W. Evans, Jr.*

10.4		Letter Agreement dated as of June 1, 2020 by and between Hanesbrands Inc. and Stephen B. Bratspies.*

31.1		Certification of Gerald W. Evans, Jr., Chief Executive Officer.

31.2		Certification of M. Scott Lewis, Interim Chief Financial Officer.

32.1		Section 1350 Certification of Gerald W. Evans, Jr., Chief Executive Officer.

32.2		Section 1350 Certification of M. Scott Lewis, Interim Chief Financial Officer.

101.INS XBRL		Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH XBRL		Taxonomy Extension Schema Document

101.CAL XBRL		Taxonomy Extension Calculation Linkbase Document

101.LAB XBRL		Taxonomy Extension Label Linkbase Document

101.PRE XBRL		Taxonomy Extension Presentation Linkbase Document

101.DEF XBRL		Taxonomy Extension Definition Linkbase Document

* Management contract or compensatory plans or arrangements.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.